_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
724352556,5/21/2015 09:27:09,1640200692,5/21/2015 09:26:43,false,clixsense,1,29688032,NLD,05,Heerlen,84.25.151.248,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION,",195-203-211,225-232-238-248,portal Liver cirrhosis TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 09:31:54,1640203169,5/21/2015 09:31:41,false,neodev,1,31911309,NLD,16,Almere,83.163.218.253,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 09:32:38,1640203563,5/21/2015 09:32:28,false,prodege,1,15439740,AUS,02,Jannali,14.200.59.55,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION, portal Liver cirrhosis",195-203-211-225-232-238,225-232-238-248-257-261-269,portal Liver cirrhosis TIMOLOL ACP Journal Club.,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 09:56:45,1640215258,5/21/2015 09:56:29,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,232-238-248,Liver cirrhosis TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:23:25,1640228549,5/21/2015 10:21:43,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:35:10,1640233882,5/21/2015 10:35:00,false,zoombucks,1,4711962,CAN,ON,Markham,174.88.29.12,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION, portal Liver cirrhosis",195-203-211-225-232-238,225-232-238-248-257-261-269,portal Liver cirrhosis TIMOLOL ACP Journal Club.,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:36:04,1640234274,5/21/2015 10:35:32,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:47:45,1640240524,5/21/2015 10:47:26,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248-257-261-269,TIMOLOL ACP Journal Club.,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:48:02,1640240696,5/21/2015 10:45:58,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352556,5/21/2015 10:49:50,1640241717,5/21/2015 10:49:26,false,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,211,248,,,223,255,HYPERTENSION,TIMOLOL,"varices HYPERTENSION,",203-211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724352557,5/21/2015 09:27:57,1640201110,5/21/2015 09:27:44,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",77-66,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 09:32:42,1640203587,5/21/2015 09:32:29,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,77,8,,,81,11,PAIN,RSD,"PAIN,",77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 09:58:03,1640215985,5/21/2015 09:57:37,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,77,8,,,81,11,PAIN,RSD,"PAIN,",77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:24:29,1640228942,5/21/2015 10:24:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:35:51,1640234192,5/21/2015 10:35:40,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,77,8,,,81,11,PAIN,RSD,"Gout Acute, spontanous PAIN, most commonly in",53-59-66-77-83-88-97,0-5-8,Pain in RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:37:13,1640235009,5/21/2015 10:36:48,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:49:01,1640241183,5/21/2015 10:48:46,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:50:59,1640242316,5/21/2015 10:50:28,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 10:55:42,1640244663,5/21/2015 10:54:42,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,77,8,,,81,11,PAIN,RSD,"Gout Acute, spontanous PAIN, metatarsophalangeal joint",53-59-66-77-106-126,8-53-59-106,"RSD Gout Acute, metatarsophalangeal","Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352557,5/21/2015 11:07:14,1640249824,5/21/2015 11:05:56,false,clixsense,1,22947672,GBR,"","",88.144.127.68,77,8,,,81,11,PAIN,RSD,"spontanous PAIN, most commonly in first metatarsophalangeal j<span id=""transmark""></span>oint",66-77-83-88-97-100-106-126,0-5-8-12-19-29-34-43-48-53-59-46,"Pain in RSD starts typically more distally in <span id=""transmark""></span>a limb Gout Acute,","Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724352558,5/21/2015 09:33:33,1640203982,5/21/2015 09:33:19,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 09:58:59,1640216499,5/21/2015 09:58:34,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:25:15,1640229298,5/21/2015 10:25:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:36:48,1640234772,5/21/2015 10:36:24,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,253,336,,,260,349,GIARDIA,METRONIDAZOLE,treatment for GIARDIA,239-249-253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:38:11,1640235479,5/21/2015 10:37:52,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:49:58,1640241809,5/21/2015 10:49:44,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:54:26,1640244040,5/21/2015 10:53:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 10:58:03,1640245735,5/21/2015 10:57:08,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,253,336,,,260,349,GIARDIA,METRONIDAZOLE,receive treatment for GIARDIA metronidazole fetal circulation.,231-239-249-253-336-388-394,307-322-326-336-350-353-361-388-394,"therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed fetal circulation.","It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 11:21:00,1640255751,5/21/2015 11:19:50,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,253,336,,,260,349,GIARDIA,METRONIDAZOLE,treatment for GIARDIA,239-249-253,336-350-353-361,METRONIDAZOLE is rapidly absorbed,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352558,5/21/2015 11:37:27,1640262909,5/21/2015 11:37:13,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724352559,5/21/2015 14:34:04,1640350831,5/21/2015 14:33:43,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 14:36:54,1640352695,5/21/2015 14:35:57,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,121,152,,,130,155,ARTHRITIS,SLE,"serositis, vasculitis, panniculitis Musculoskeletal ARTHRITIS Peripheral vascular Asymmetry",37-52-99-121-178-189-204-26,26-37-99-121-136-144-147-152-156-160-163-178-189-217-243-252-204,"serositis, vasculitis, Musculoskeletal Arthritis feature of both SLE and WG Physical Peripheral vascular Asymmetry pulses vascular bruits","Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 14:48:51,1640359636,5/21/2015 14:48:33,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,121,152,,,130,155,ARTHRITIS,SLE,Musculoskeletal exam ARTHRITIS is a feature of both SLE and WG Physical exam,99-115-121-131-134-136-144-147-152-156-160-163-172,136-144-147-152-156-160-163,feature of both SLE and WG Physical,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 15:18:01,1640375782,5/21/2015 15:16:40,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 15:58:14,1640399717,5/21/2015 15:57:44,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 16:13:21,1640408762,5/21/2015 16:12:41,false,instagc,1,30758231,USA,NY,Oneida,67.249.200.111,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 16:16:30,1640411026,5/21/2015 16:16:14,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152-156-160-163-172,SLE and WG Physical exam,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 16:30:59,1640420735,5/21/2015 16:29:28,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,121,152,,,130,155,ARTHRITIS,SLE,Musculoskeletal exam ARTHRITIS,99-115-121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 16:42:04,1640427902,5/21/2015 16:40:27,false,points4rewards,1,28703583,USA,"","",97.73.83.199,121,152,,,130,155,ARTHRITIS,SLE,SLE Physical exam Musculoskeletal exam ARTHRITIS,80-84-99-115-121-93,80-84-93-99-115-152-121,SLE Physical exam Musculoskeletal exam Arthritis SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352559,5/21/2015 16:46:47,1640431346,5/21/2015 16:45:25,false,vivatic,1,32338429,GBR,G1,Feltham,92.24.40.208,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS is a feature of both SLE and WG,121-131-134-136-144-147-152-156-160,121-131-134-136-144-147-152-156-160,Arthritis is a feature of both SLE and WG,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724352560,5/21/2015 10:00:48,1640217367,5/21/2015 10:00:28,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"HALLUCINATIONS,",107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 10:27:30,1640230232,5/21/2015 10:27:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 10:40:08,1640236415,5/21/2015 10:39:33,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 10:51:33,1640242626,5/21/2015 10:51:12,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 10:57:46,1640245638,5/21/2015 10:57:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"visual HALLUCINATIONS,",100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 11:28:25,1640258806,5/21/2015 11:25:39,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21-28-31-33-45-55-63-68-80,"DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating s<span id=""transmark""></span>ymptoms,","◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 11:38:38,1640263649,5/21/2015 11:38:24,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"HALLUCINATIONS,",107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 11:58:07,1640272489,5/21/2015 11:56:42,false,clixsense,1,15673340,CAN,ON,Dundas,174.88.17.69,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"symptoms, recurrent visual HALLUCINATIONS, and spontaneous, extrapyramidal",80-90-100-107-123-127-140,0-2-11-16-21-28-31-33-45-55,◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 12:22:08,1640282958,5/21/2015 12:20:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"HALLUCINATIONS,",107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352560,5/21/2015 12:36:29,1640289333,5/21/2015 12:35:50,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"Dementia HALLUCINATIONS,",107-2,2-11-16-21-33-45-55,DEMENTIA WITH LEWY BODIES progressive cognitive decline,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724352561,5/21/2015 07:45:15,1640147401,5/21/2015 07:44:59,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 07:54:55,1640152757,5/21/2015 07:54:34,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 08:01:42,1640156160,5/21/2015 08:01:19,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 08:12:09,1640161828,5/21/2015 08:11:50,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 08:29:28,1640171280,5/21/2015 08:28:57,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,160,245,,,169,257,PSORIASIS,METHOTREXATE,plaque PSORIASIS,153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 08:32:38,1640173113,5/21/2015 08:32:12,false,prodege,1,16101132,GBR,G1,Hounslow,90.207.88.197,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 09:16:15,1640195446,5/21/2015 09:15:44,false,neodev,1,11001780,AUS,07,Elwood,14.201.215.31,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 09:21:03,1640197615,5/21/2015 09:20:43,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS is,140-153-160-175,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 09:26:04,1640200180,5/21/2015 09:25:40,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,160,245,,,169,257,PSORIASIS,METHOTREXATE,PSORIASIS,160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352561,5/21/2015 09:26:53,1640200571,5/21/2015 09:26:28,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,160,245,,,169,257,PSORIASIS,METHOTREXATE,PSORIASIS,160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724352562,5/21/2015 13:24:21,1640310777,5/21/2015 13:23:59,false,instagc,1,15285653,USA,"","",172.162.76.35,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,SYN: otoscope ENDOTOXEMIA Toxemia due to the presence of endotoxins in the blood.,0-7-19-65-73-77-80-84-93-96-107-110-114,0-7-19-65-73-80-84-93-96-107-110-114-77,SYN: otoscope endotoxemia Toxemia due to the presence of ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 13:33:38,1640315413,5/21/2015 13:33:12,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 13:39:27,1640318276,5/21/2015 13:39:05,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,7-19,80-84-93-96-107-110-114,the presence of ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 13:56:47,1640327484,5/21/2015 13:56:34,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 14:29:21,1640347935,5/21/2015 14:28:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 14:30:38,1640348704,5/21/2015 14:30:13,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA audio Toxemia,7-19-56-65,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 14:32:19,1640349638,5/21/2015 14:31:52,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,SYN: otoscope ENDOTOXEMIA audio Toxemia,0-7-19-56-65,80-84-93-96-107-110-114-65,Toxemia the presence of ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 14:46:36,1640358381,5/21/2015 14:46:20,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,SYN: otoscope ENDOTOXEMIA audio Toxemia due to the presence of endotoxins in the blood.,0-7-19-56-65-73-77-80-84-93-96-107-110-114,65-73-80-84-93-96-107-110-114-77,Toxemia due to the presence of ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 15:09:29,1640371008,5/21/2015 15:08:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA audio Toxemia,7-19-56-65,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352562,5/21/2015 15:22:30,1640378276,5/21/2015 15:22:17,false,neodev,1,32491845,USA,"","",208.31.49.58,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,SYN: otoscope ENDOTOXEMIA audio Toxemia due,0-7-19-56-65-73,80-84-93-96-107-110-114,the presence of ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724352563,5/21/2015 09:20:52,1640197555,5/21/2015 09:20:35,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 09:25:05,1640199611,5/21/2015 09:24:49,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 09:29:58,1640202148,5/21/2015 09:29:45,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,184,131,,,190,136,RABIES,VIRUS,RABIES.,184,131,VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 09:30:54,1640202671,5/21/2015 09:30:43,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,131-124,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 09:51:29,1640212733,5/21/2015 09:51:19,false,clixsense,1,27754226,GBR,O3,South Ockendon,92.232.236.243,184,131,,,190,136,RABIES,VIRUS,RABIES.,184,131,VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 09:53:35,1640213718,5/21/2015 09:53:07,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,184,131,,,190,136,RABIES,VIRUS,encephalitic RABIES.,184-158,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 10:09:32,1640221742,5/21/2015 10:09:11,false,vivatic,1,13889585,GBR,A1,Dagenham,2.28.66.9,184,131,,,190,136,RABIES,VIRUS,encephalitic paralytic RABIES.,158-174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 10:19:49,1640226854,5/21/2015 10:18:25,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,184,131,,,190,136,RABIES,VIRUS,encephalitic or paralytic RABIES.,158-171-174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 10:25:58,1640229667,5/21/2015 10:24:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352563,5/21/2015 10:33:40,1640233167,5/21/2015 10:33:09,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,184,131,,,190,136,RABIES,VIRUS,encephalitic or paralytic RABIES.,158-171-174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724352564,5/21/2015 07:18:40,1640133337,5/21/2015 07:17:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,143,205,,,151,215,SEIZURE,RED FIBER,"Myoclonic epilepsy with ragged red fibers (MERRF): This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic SEIZURES), dementia, ataxia, and myopathy, which shows ragged red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",0-10-19-24-31-35-42-52-57-60-62-74-82-96-99-112-119-132-143-154-164-172-176-186-192-198-205-209-216-228-242-257-262-274-281-286,0-10-19-24-31-35-42-52-57-60-62-74-82-96-99-112-119-132-143-154-164-172-176-186-192-198-205-209-216-228-242-257-262-274-281-286,"Myoclonic epilepsy with ragged red fibers (MERRF): This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.","Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 07:30:23,1640139502,5/21/2015 07:30:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 07:47:43,1640148676,5/21/2015 07:47:27,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 07:54:53,1640152713,5/21/2015 07:54:28,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES), and myopathy,",132-143-172-176,205-209,RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 07:57:55,1640154198,5/21/2015 07:57:29,false,prodege,1,18793920,USA,CA,Salinas,73.162.0.87,143,205,,,151,215,SEIZURE,RED FIBER,"Myoclonic epilepsy muscle contractions (myoclonic SEIZURES), dementia, ataxia, and",0-112-119-132-143-154-164-172-10,0-10-143-186-192-198-205-209-228-242-132,"Myoclonic epilepsy (myoclonic seizures), which shows ragged RED FIBERS mitochondrial proliferation)","Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 08:06:31,1640158738,5/21/2015 08:06:15,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 08:22:24,1640167479,5/21/2015 08:22:04,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 08:22:49,1640167686,5/21/2015 08:22:30,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 09:05:23,1640189748,5/21/2015 09:05:10,false,prodege,1,22031444,GBR,B7,Bristol,92.236.71.128,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352564,5/21/2015 09:09:46,1640192079,5/21/2015 09:09:25,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724352565,5/21/2015 07:22:56,1640135673,5/21/2015 07:22:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,118,42,,,128,49,RHINOPHYMA,ROSACEA,"Some patients go on to develop late stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",0-5-14-17-20-23-31-36-42-51-65-68-75-82-94-97-101-108-112-117-130-137-140-147-161-170-182-186-196-202,0-5-14-17-20-23-31-36-42-51-65-68-75-82-94-97-101-108-112-117-130-137-140-147-161-170-182-186-196-202,"Some patients go on to develop late stage ROSACEA, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 07:37:27,1640143262,5/21/2015 07:36:29,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,118,42,,,128,49,RHINOPHYMA,ROSACEA,nose (RHINOPHYMA),117-112,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 07:51:36,1640150798,5/21/2015 07:51:10,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 07:58:40,1640154590,5/21/2015 07:58:21,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,42,"ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 08:00:20,1640155491,5/21/2015 08:00:06,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,118,42,,,128,49,RHINOPHYMA,ROSACEA,and nose (RHINOPHYMA) caused by tissue sebaceous gland hyperplasia.,108-112-117-130-137-140-186-202-196,23-31-36-42-51-65-68-202-196,"develop late stage ROSACEA, characterized by coarse gland hyperplasia.","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 08:09:20,1640160278,5/21/2015 08:08:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 08:26:13,1640169563,5/21/2015 08:25:49,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 08:28:56,1640170954,5/21/2015 08:28:32,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 09:07:18,1640190667,5/21/2015 09:07:04,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352565,5/21/2015 09:13:32,1640194072,5/21/2015 09:12:59,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,42,"ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724352566,5/21/2015 10:42:57,1640237957,5/21/2015 10:42:39,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 10:53:17,1640243504,5/21/2015 10:53:04,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 11:04:16,1640248636,5/21/2015 11:02:53,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 11:40:33,1640264423,5/21/2015 11:40:20,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,119,79,,,129,86,INFARCTION,ASPIRIN,INFARCTION,119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 11:47:14,1640267628,5/21/2015 11:46:42,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,119,79,,,129,86,INFARCTION,ASPIRIN,aspirin reduces the risk for myocardial INFARCTION,79-87-95-99-104-108-119,79-87-95-99-104-119-108,"ASPIRIN reduces the risk for myoc<span id=""transmark""></span>ardial infarction","CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 12:37:44,1640289870,5/21/2015 12:37:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,119,79,,,129,86,INFARCTION,ASPIRIN,"vascular disease, INFARCTION",61-119-70,79-163,ASPIRIN stroke,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 12:43:54,1640292774,5/21/2015 12:43:31,false,prodege,1,3587109,CAN,NS,Mabou,47.55.139.253,119,79,,,129,86,INFARCTION,ASPIRIN,aspirin reduces the risk for myocardial INFARCTION but does not,79-87-99-104-108-119-130-134-139-95,58-61-70-79-87-95-99-104-108-119-130-139-143-154-163-170-173-182,"of vascular disease, ASPIRIN reduces the risk for myocardial infarction but not reduce risk stroke or vascular death.","CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 12:57:28,1640298359,5/21/2015 12:57:08,false,clixsense,1,24329110,USA,FL,Jacksonville,12.168.136.2,119,79,,,129,86,INFARCTION,ASPIRIN,"vascular disease, risk for myocardial INFARCTION",61-99-104-108-119-70,58-61-70-79-87-95-99,"of vascular disease, ASPIRIN reduces the risk","CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 13:01:16,1640299882,5/21/2015 12:59:17,false,instagc,1.0,15285653,USA,"","",172.162.76.35,119,79,,,129,86,INFARCTION,ASPIRIN,risk for myocardial INFARCTION but does not reduce the risk for stroke vascular death.,99-104-108-119-130-134-139-143-150-154-159-163-173-182,58-61-70-79-87-95-99-104-108-119-130-134-139-143-150-154-159-163-170-173-182,"of vascular disease, ASPIRIN reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.","CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352566,5/21/2015 13:13:35,1640305168,5/21/2015 13:12:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724352567,5/21/2015 09:59:54,1640216978,5/21/2015 09:59:33,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 10:26:06,1640229721,5/21/2015 10:25:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-130-121,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 10:38:59,1640235813,5/21/2015 10:38:30,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-130-121,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 10:50:33,1640242104,5/21/2015 10:50:16,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 10:55:23,1640244536,5/21/2015 10:55:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 10:59:05,1640246290,5/21/2015 10:58:47,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,of Pneumocystis carinii PNEUMONIA,104-108-121-130,29-32-35-39-51-55-66,RL et al. CLINDAMYCIN and primaquine therapy,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 11:24:22,1640257163,5/21/2015 11:21:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,"Pneumocystis ca<span id=""transmark""></span>rinii PNEUMONIA in patients with AIDS:",108-130-140-143-152-157-121,39-51-55-66-74-78-83-86-95-104-108-121-130,"CLINDAMYCIN and primaquine therapy for mild to moderate episodes of Pneumocystis carinii pne<span id=""transmark""></span>umonia","Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 11:37:56,1640263119,5/21/2015 11:37:41,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,PNEUMONIA,130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 11:55:17,1640271254,5/21/2015 11:53:27,false,clixsense,1.0,15673340,CAN,ON,Dundas,174.88.17.69,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,of Pneumocystis carinii PNEUMONIA in patients with,104-121-130-140-143-152-108,29-32-35-39-51-55-66,RL et al. CLINDAMYCIN and primaquine therapy,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352567,5/21/2015 12:08:29,1640277085,5/21/2015 12:08:26,false,neodev,1,31789301,USA,NY,New York,198.199.68.152,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,of Pneumocystis carinii PNEUMONIA in patients with,104-108-121-130-140-143-152,29-32-35-39-51-55-66,RL et al. CLINDAMYCIN and primaquine therapy,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724352568,5/21/2015 07:17:06,1640132401,5/21/2015 07:16:29,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,42,0,,,48,13,CORNEA,KERATOUVEITIS,"keratouveitis Inflammation of both the CORNEA and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",0-17-30-33-38-42-49-53-57-63-69-76-79-84-88-95-99-103-109-117-123-127,0-17-30-33-38-42-49-53-57-63-69-76-79-84-88-95-99-103-109-117-123-127,"KERATOUVEITIS Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.","keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:21:11,1640134725,5/21/2015 07:18:57,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:29:01,1640138803,5/21/2015 07:28:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:34:49,1640141876,5/21/2015 07:34:40,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-30,KERATOUVEITIS of,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:46:53,1640148265,5/21/2015 07:46:13,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:53:48,1640152117,5/21/2015 07:53:28,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 07:56:39,1640153652,5/21/2015 07:56:21,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,42,0,,,48,13,CORNEA,KERATOUVEITIS,keratouveitis Inflammation of both the CORNEA and the uveal,0-30-33-38-42-49-53-57-17,0-17-30-33-42-57-63,KERATOUVEITIS Inflammation of both cornea uveal tract,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 08:00:48,1640155694,5/21/2015 08:00:29,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 08:05:45,1640158369,5/21/2015 08:05:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352568,5/21/2015 08:21:42,1640167009,5/21/2015 08:21:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724352569,5/21/2015 10:01:30,1640217720,5/21/2015 10:00:48,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 10:27:55,1640230436,5/21/2015 10:27:32,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 10:40:28,1640236575,5/21/2015 10:40:09,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 10:51:49,1640242794,5/21/2015 10:51:34,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 10:58:10,1640245800,5/21/2015 10:57:50,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 11:33:32,1640261106,5/21/2015 11:32:13,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,2-13-16-19-26-29,Management in PV should be individualized,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 11:38:55,1640263735,5/21/2015 11:38:40,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 12:00:13,1640273331,5/21/2015 11:58:09,false,clixsense,1.0,15673340,CAN,ON,Dundas,174.88.17.69,96,16,,,106,18,THROMBOSIS,PV,"presence or absence of risk factors for THROMBOSIS, and childbearing potential.",56-65-68-79-84-92-96-108-112-125-76,0-2-13-16-19-26-29-44-47,"• Management in PV should be individualized by age,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 12:34:19,1640288453,5/21/2015 12:33:54,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,96,16,,,106,18,THROMBOSIS,PV,"PV THROMBOSIS,",96-16,16-96,"PV thrombosis,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352569,5/21/2015 12:41:18,1640291629,5/21/2015 12:40:48,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,96,16,,,106,18,THROMBOSIS,PV,"Management in PV risk factors for THROMBOSIS, and childbearing potential.",2-13-79-84-92-96-108-112-125-16,0-2-13-16-19-26-29-44-47-56-68-79-84-96-112-125,"• Management in PV should be individualized by age, presence absence risk factors thrombosis, childbearing potential.","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724352570,5/21/2015 07:21:13,1640134748,5/21/2015 07:20:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,"Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA.",2-15-19-31-42-47-56-59-61-69-75-82-91-95-98-101-113-120-131-142-151-155-157-174-138,2-15-19-31-42-47-56-59-61-69-75-82-91-95-98-101-113-120-131-138-142-151-155-157-174,"Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a supraventricular tachycardia.","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 07:33:15,1640141140,5/21/2015 07:33:01,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 07:49:52,1640149766,5/21/2015 07:49:35,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 07:57:04,1640153848,5/21/2015 07:56:46,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 07:59:17,1640155000,5/21/2015 07:58:55,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,Hypoglycemia respiratory propranolol delivery for a SUPRAVENTRICULAR TACHYCARDIA.,2-19-142-151-155-157-174-101,2-19-91-95-98-101-113-131-120,"Hypoglycemia respiratory 160 mg of PROPRANOLOL during pregnancy, labor,","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 08:08:00,1640159599,5/21/2015 08:07:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101-113-120,"PROPRANOLOL during pregnancy,","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 08:24:45,1640168794,5/21/2015 08:24:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 08:26:51,1640169920,5/21/2015 08:26:34,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 09:06:22,1640190162,5/21/2015 09:06:10,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352570,5/21/2015 09:11:17,1640192835,5/21/2015 09:10:59,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724352571,5/21/2015 12:44:19,1640292949,5/21/2015 12:43:52,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,116,62,,,124,74,DISORDER,CLOMIPRAMINE,treatment of obsessive compulsive DISORDER:,82-92-95-116-105,62-82-92-95-105-116,CLOMIPRAMINE treatment of obsessive compulsive disorder:,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 12:50:05,1640295352,5/21/2015 12:49:46,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,116,62,,,124,74,DISORDER,CLOMIPRAMINE,"Fluvoxamine versus clomipramine in treatment of obsessive compulsive DISORDER: a multicenter, randomized,",43-55-62-75-92-95-105-116-126-128-141-82,39-43-55-62-75-78-82-92-95-105-116,al. Fluvoxamine versus CLOMIPRAMINE in the treatment of obsessive compulsive disorder:,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 13:15:17,1640306136,5/21/2015 13:14:37,false,instagc,1.0,15285653,USA,"","",172.162.76.35,116,62,,,124,74,DISORDER,CLOMIPRAMINE,"Fluvoxamine versus clomipramine in the treatment of obsessive compulsive DISORDER: a multicenter, randomized, double blind, parallel group comparison.",43-55-62-75-78-82-92-95-105-116-126-128-141-153-160-167-176-182,43-55-62-75-78-82-92-95-105-116-126-128-141-153-160-167-176-182,"Fluvoxamine versus CLOMIPRAMINE in the treatment of obsessive compulsive disorder: a multicenter, randomized, double blind, parallel group comparison.","Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 13:28:15,1640312684,5/21/2015 13:27:55,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 13:34:01,1640315738,5/21/2015 13:33:11,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,116,62,,,124,74,DISORDER,CLOMIPRAMINE,of obsessive compulsive DISORDER:,92-95-105-116,43-55-62-75-78-82,Fluvoxamine versus CLOMIPRAMINE in the treatment,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 13:53:50,1640325605,5/21/2015 13:53:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 14:22:59,1640343695,5/21/2015 14:22:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 14:24:59,1640345147,5/21/2015 14:23:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,116,62,,,124,74,DISORDER,CLOMIPRAMINE,"Fluvoxamine clomipramine of obsessive compulsive DISORDER: a multicenter, randomized, double blind, parallel group comparison.",43-62-92-95-105-116-126-128-141-153-160-167-176-182,39-43-55-62-75-78-82-95-105-116-128-141-153-160-167-176-182,"al. Fluvoxamine versus CLOMIPRAMINE in the treatment obsessive compulsive disorder: multicenter, randomized, double blind, parallel group comparison.","Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 14:25:17,1640345346,5/21/2015 14:25:03,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352571,5/21/2015 14:27:08,1640346435,5/21/2015 14:26:54,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724352572,5/21/2015 07:20:24,1640134374,5/21/2015 07:20:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,Intravenous or inhaled pentamidine for treating PNEUMOCYSTIS carinii pneumonia in AIDS:,45-57-60-68-80-84-95-108-117-127-130,45-57-60-68-80-84-95-108-117-127-130,Intravenous or inhaled PENTAMIDINE for treating Pneumocystis carinii pneumonia in AIDS:,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 07:33:00,1640140972,5/21/2015 07:31:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,95,60-68,inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 07:49:34,1640149596,5/21/2015 07:49:11,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,95,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 07:56:45,1640153700,5/21/2015 07:56:17,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 07:58:54,1640154767,5/21/2015 07:58:25,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,Intravenous pentamidine for treating PNEUMOCYSTIS carinii pneumonia in randomized,45-68-80-84-95-108-117-127-138,45-57-60-68-80-84-95-108-117,Intravenous or inhaled PENTAMIDINE for treating Pneumocystis carinii pneumonia,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 08:07:40,1640159367,5/21/2015 08:07:15,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,95,60-68,inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 08:24:28,1640168562,5/21/2015 08:24:04,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,95,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 08:26:33,1640169729,5/21/2015 08:25:43,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,45-57-60-68,Intravenous or inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 09:06:09,1640190074,5/21/2015 09:05:56,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,45-57-60-68,Intravenous or inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352572,5/21/2015 09:10:58,1640192707,5/21/2015 09:10:32,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724352573,5/21/2015 07:19:25,1640133828,5/21/2015 07:18:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,51,152,,,61,157,INFECTION,VIRUS,Prevention of Avian Influenza A Virus INFECTIONS Oral Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.,13-24-27-33-43-45-51-73-79-86-94-106-110-122-125-134-144-146-150-152-158-169-173-178,13-24-27-33-43-45-51-73-79-86-94-106-110-122-125-134-144-146-150-152-158-169-173-178,Prevention of Avian Influenza A Virus Infections Oral Dosage usually recommended for prophylaxis of seasonal influenza A and B VIRUS infections has been recommended.,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 07:30:51,1640139906,5/21/2015 07:30:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza A Virus INFECTIONS,27-33-43-45-51,134-144-146-150-152-158-125,seasonal influenza A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 07:48:13,1640148881,5/21/2015 07:47:45,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza A Virus INFECTIONS,27-33-43-45-51,152,VIRUS,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 07:55:50,1640153281,5/21/2015 07:54:54,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,51,152,,,61,157,INFECTION,VIRUS,INFECTIONS,51,134-144-146-152-150,influenza A and B VIRUS,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 07:58:07,1640154297,5/21/2015 07:57:57,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza A Virus INFECTIONS Oral Dosage usually prophylaxis,27-33-43-45-51-73-79-86-110,144-146-150-152-158-169-173-110,prophylaxis A and B VIRUS infections has been,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 08:06:51,1640158875,5/21/2015 08:06:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,152-158,VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 08:23:37,1640168092,5/21/2015 08:22:50,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza A Virus INFECTIONS,33-43-45-51-27,134-144-146-150-152-158,influenza A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 08:25:09,1640168968,5/21/2015 08:22:25,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 09:05:38,1640189850,5/21/2015 09:05:24,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,125-144-146-150-152-158-134,seasonal influenza A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352573,5/21/2015 09:10:04,1640192181,5/21/2015 09:09:47,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724352574,5/21/2015 10:00:27,1640217240,5/21/2015 10:00:15,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,108,149,,,115,157,SEIZURE,EPILEPSY,SEIZURE,108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 10:27:12,1640230100,5/21/2015 10:27:01,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 10:39:32,1640236062,5/21/2015 10:39:18,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 10:51:10,1640242439,5/21/2015 10:50:59,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 10:57:01,1640245246,5/21/2015 10:56:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 10:59:48,1640246670,5/21/2015 10:59:32,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,108,149,,,115,157,SEIZURE,EPILEPSY,child's febrile SEIZURE,92-100-108,100-138-141-145-149-108,febrile seizure or she has EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 11:25:38,1640257620,5/21/2015 11:24:59,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,108,149,,,115,157,SEIZURE,EPILEPSY,child's febrile SEIZURE,92-100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 11:38:23,1640263421,5/21/2015 11:38:10,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,108,149,,,115,157,SEIZURE,EPILEPSY,SEIZURE,108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 11:56:41,1640271917,5/21/2015 11:55:53,false,clixsense,1.0,15673340,CAN,ON,Dundas,174.88.17.69,108,149,,,115,157,SEIZURE,EPILEPSY,child's febrile SEIZURE does not mean he or she has epilepsy.,92-100-108-116-121-125-135-138-141-145-149,100-108-121-125-135-138-141-145-149-116,febrile seizure does not mean he or she has EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352574,5/21/2015 12:20:53,1640282422,5/21/2015 12:20:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724352575,5/21/2015 07:17:52,1640132819,5/21/2015 07:17:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,32,0,,,36,9,LOUSE,MALATHION,Malathion for treatment of head LICE.,0-14-24-27-32-10,0-10-14-24-27-32,MALATHION for treatment of head lice.,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 07:21:38,1640134897,5/21/2015 07:21:29,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 07:30:06,1640139394,5/21/2015 07:29:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 07:47:25,1640148531,5/21/2015 07:47:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,32,0,,,36,9,LOUSE,MALATHION,LICE.,32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 07:54:27,1640152442,5/21/2015 07:54:14,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 07:57:28,1640153955,5/21/2015 07:57:04,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,32,0,,,36,9,LOUSE,MALATHION,Malathion treatment of head LICE.,14-24-27-32-0,0-10-14-24-27-32,MALATHION for treatment of head lice.,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 08:01:20,1640155969,5/21/2015 08:01:09,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 08:06:14,1640158595,5/21/2015 08:06:04,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 08:22:28,1640167524,5/21/2015 08:22:15,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352575,5/21/2015 08:25:38,1640169224,5/21/2015 08:25:31,false,cointasker,1,21783324,NLD,11,Schiedam,194.13.104.194,32,0,,,36,9,LOUSE,MALATHION,head LICE.,32-27,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724352576,5/21/2015 08:14:41,1640163097,5/21/2015 08:14:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 08:32:23,1640172908,5/21/2015 08:32:03,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:19:33,1640196971,5/21/2015 09:19:06,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:23:52,1640198943,5/21/2015 09:23:38,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:28:56,1640201701,5/21/2015 09:28:31,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,110,SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:29:49,1640202061,5/21/2015 09:29:34,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:50:36,1640212251,5/21/2015 09:50:22,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,110,SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 09:51:53,1640212805,5/21/2015 09:51:20,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS Bartonella,64-74-98,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 10:07:46,1640220896,5/21/2015 10:07:04,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352576,5/21/2015 10:17:29,1640225632,5/21/2015 10:17:01,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724352577,5/21/2015 13:57:53,1640328243,5/21/2015 13:57:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 14:30:51,1640348825,5/21/2015 14:30:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 14:31:32,1640349285,5/21/2015 14:31:22,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 14:34:16,1640351037,5/21/2015 14:34:00,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,77,41,,,85,45,TOXICITY,DRUG,"concentrations, producing drug TOXICITY.",46-62-72-77,12-16-32-41-46-62-72-77,"may unintentionally increase DRUG concentrations, producing drug toxicity.","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 14:47:39,1640359102,5/21/2015 14:47:25,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,77,41,,,85,45,TOXICITY,DRUG,"Rewarming may unintentionally increase drug concentrations, producing drug TOXICITY.",2-12-16-32-46-62-72-77-41,12-16-32-41-46-62-72-77,"may unintentionally increase DRUG concentrations, producing drug toxicity.","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 15:13:00,1640373068,5/21/2015 15:12:27,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-77,DRUG toxicity.,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 15:33:26,1640383916,5/21/2015 15:33:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,77-72,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 15:49:07,1640393623,5/21/2015 15:48:57,false,instagc,1,23032978,USA,PA,Philadelphia,76.98.187.59,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 15:56:43,1640398753,5/21/2015 15:56:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41-77,DRUG toxicity.,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352577,5/21/2015 16:10:39,1640407374,5/21/2015 16:09:30,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724352578,5/21/2015 09:26:01,1640200108,5/21/2015 09:25:50,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,61,14,,,65,17,PAIN,PHN,"PAIN,",61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 09:30:59,1640202698,5/21/2015 09:30:45,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,61,14,,,65,17,PAIN,PHN,"PAIN,",61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 09:31:53,1640203165,5/21/2015 09:31:40,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 09:55:07,1640214463,5/21/2015 09:54:52,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,61,14,,,65,17,PAIN,PHN,"PAIN,",61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:11:28,1640222651,5/21/2015 10:11:11,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,61,14,,,65,17,PAIN,PHN,"continuous burning dermatomal PAIN,",31-42-50-61,0-9-14,Patients with PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:21:07,1640227450,5/21/2015 10:20:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,61,14,,,65,17,PAIN,PHN,"continuous burning dermatomal PAIN,",31-42-50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:34:28,1640233572,5/21/2015 10:34:15,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,61,14,,,65,17,PAIN,PHN,"continuous burning dermatomal PAIN,",31-42-50-61,0-9-14-18,Patients with PHN experience,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:34:51,1640233740,5/21/2015 10:34:34,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:43:12,1640238065,5/21/2015 10:42:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352578,5/21/2015 10:46:47,1640239971,5/21/2015 10:46:35,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724352579,5/21/2015 09:20:32,1640197430,5/21/2015 09:20:13,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 09:24:48,1640199440,5/21/2015 09:24:21,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 09:29:43,1640202053,5/21/2015 09:29:30,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,14,71,,,18,81,PAIN,VULVODYNIA,PAIN,14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 09:30:40,1640202582,5/21/2015 09:30:29,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 09:51:16,1640212603,5/21/2015 09:51:02,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,14,71,,,18,81,PAIN,VULVODYNIA,PAIN,14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 09:53:06,1640213421,5/21/2015 09:52:46,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 10:09:09,1640221534,5/21/2015 10:08:43,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 10:18:24,1640226119,5/21/2015 10:18:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 10:24:56,1640229142,5/21/2015 10:23:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,14,71,,,18,81,PAIN,VULVODYNIA,Neuropathic PAIN,2-14,58-71-52,vulva (generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352579,5/21/2015 10:33:08,1640232948,5/21/2015 10:32:45,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,14,71,,,18,81,PAIN,VULVODYNIA,Neuropathic PAIN,2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724352580,5/21/2015 07:16:27,1640132099,5/21/2015 07:15:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,"Erysipelothrix rhusiopathiae Infections Treatment of infections caused by Erysipelothrix rhusiopathiae , including ERYSIPELOID or endocarditis.",3-18-32-44-54-57-68-75-94-108-110-120-132-135-79,3-18-32-44-54-57-68-75-79-94-110-120-132-135,Erysipelothrix rhusiopathiae Infections Treatment of infections caused by ERYSIPELOTHRIX RHUSIOPATHIAE including erysipeloid or endocarditis.,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:18:56,1640133428,5/21/2015 07:18:42,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:28:45,1640138676,5/21/2015 07:28:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,", ERYSIPELOID",108-120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:34:39,1640141741,5/21/2015 07:34:26,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:46:12,1640147919,5/21/2015 07:45:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:53:26,1640151887,5/21/2015 07:53:01,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,", ERYSIPELOID",108-120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 07:56:19,1640153488,5/21/2015 07:55:58,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,"Erysipelothrix rhusiopathiae Infections Treatment Erysipelothrix rhusiopathiae , including ERYSIPELOID or endocarditis.",3-18-32-79-94-108-110-120-132-135-44,18-44-57-68-75-79-94-110-120-132-3,Erysipelothrix rhusiopathiae Treatment infections caused by ERYSIPELOTHRIX RHUSIOPATHIAE including erysipeloid or,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 08:00:28,1640155542,5/21/2015 07:59:57,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 08:05:26,1640158186,5/21/2015 08:05:01,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352580,5/21/2015 08:21:22,1640166880,5/21/2015 08:20:54,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724352581,5/21/2015 09:26:23,1640200306,5/21/2015 09:26:02,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 09:31:14,1640202853,5/21/2015 09:31:00,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,36,99,,,45,103,REACTION,DRUG,REACTIONS,36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 09:32:09,1640203322,5/21/2015 09:31:55,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 09:56:05,1640214934,5/21/2015 09:55:07,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-31-36-14,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:21:30,1640227619,5/21/2015 10:21:08,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,36,99,,,45,103,REACTION,DRUG,Hypersensitivity drug REACTIONS,14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:34:43,1640233665,5/21/2015 10:34:28,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,99-105-109-125,"DRUG, its administration, and","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:35:11,1640233894,5/21/2015 10:34:52,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,36,99,,,45,103,REACTION,DRUG,drug REACTIONS,31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:44:11,1640238667,5/21/2015 10:43:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,36,99,,,45,103,REACTION,DRUG,drug REACTIONS,36-31,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:47:06,1640240131,5/21/2015 10:46:48,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,36,99,,,45,103,REACTION,DRUG,drug REACTIONS,31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352581,5/21/2015 10:49:10,1640241272,5/21/2015 10:48:49,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,36,99,,,45,103,REACTION,DRUG,drug REACTIONS,31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724352582,5/21/2015 07:01:21,1640123933,5/21/2015 07:01:07,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,falciparum malaria control group without MALARIA or treatment with,35-273-281-287-295-303-306-316-47,35-303-306-316-321-334-341-348-47,falciparum malaria or treatment with ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:14:45,1640131117,5/21/2015 07:12:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,"180 In a study in women with P. falciparum malaria who received a 7 - day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at &gt;28 weeks of gestation or overall rate of congenital malformations compared with a control group without MALARIA or treatment with antimalarial agents during pregnancy.",6-9-11-17-20-26-32-35-47-55-59-68-70-71-72-76-84-87-92-100-107-115-122-125-136-142-146-149-160-163-167-172-175-187-190-194-200-203-213-216-224-229-232-243-257-266-271-273-281-287-295-303-306-316-321-334-341-348-0,0-6-9-11-17-20-26-32-35-47-55-59-68-70-72-76-84-87-92-100-107-115-122-125-136-142-146-149-160-163-167-172-175-187-190-194-200-203-213-216-224-229-232-243-257-266-271-273-281-287-303-306-316-321-334-341-348-295,"180 In a study in women with P. falciparum malaria who received a 7 day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at &gt;28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with ANTIMALARIAL AGENTS during pregnancy.","180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:18:29,1640133201,5/21/2015 07:18:18,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:27:51,1640138117,5/21/2015 07:27:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:33:59,1640141490,5/21/2015 07:33:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:45:29,1640147531,5/21/2015 07:45:13,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:51:14,1640150531,5/21/2015 07:51:07,false,elite,1,31913360,GBR,"","",88.150.133.60,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,control group without MALARIA or treatment with,273-281-287-295-303-306-316,303-306-316-321-334-341-348,or treatment with ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:52:24,1640151209,5/21/2015 07:51:59,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:55:12,1640152910,5/21/2015 07:54:40,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,oral quinine MALARIA treatment,87-92-295-306,87-92-303-306-316-321-334-341-348-76,regimen oral quinine or treatment with ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352582,5/21/2015 07:59:24,1640155041,5/21/2015 07:59:02,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724352583,5/21/2015 07:01:31,1640124019,5/21/2015 07:01:22,false,clixsense,1.0,6352682,GBR,H9,London,2.122.19.138,21,95,,,26,108,COUGH,HYDROCHLORIDE,Seltzer Plus ® COUGH and Cold,5-13-18-21-27-31,52-69-78-95-110-114-128,"chlorpheniramine maleate, dextromethorphan HYDROCHLORIDE, and phenylephrine hydrochloride)","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:15:34,1640131570,5/21/2015 07:14:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,21,95,,,26,108,COUGH,HYDROCHLORIDE,"COUGH and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride)",21-27-31-36-52-69-78-95-110-114-128,21-27-31-52-69-78-95-110-114-128-36,"Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan HYDROCHLORIDE, and phenylephrine hydrochloride)","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:18:41,1640133335,5/21/2015 07:18:30,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:28:25,1640138526,5/21/2015 07:27:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:34:25,1640141658,5/21/2015 07:34:00,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,95,"HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:45:53,1640147708,5/21/2015 07:45:31,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:53:00,1640151605,5/21/2015 07:52:25,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,95,"HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:55:56,1640153297,5/21/2015 07:55:13,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,21,95,,,26,108,COUGH,HYDROCHLORIDE,"Seltzer Plus ® COUGH and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride,",5-13-18-21-27-31-36-52-69-78-95,5-21-52-69-78-95-110-114-128-36,"Seltzer Cough (acetaminophen, chlorpheniramine maleate, dextromethorphan HYDROCHLORIDE, and phenylephrine hydrochloride)","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 07:59:56,1640155320,5/21/2015 07:59:24,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold,0-13-18-21-27-31-5,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352583,5/21/2015 08:04:58,1640157949,5/21/2015 08:04:33,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724352584,5/21/2015 07:24:25,1640136479,5/21/2015 07:24:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,36,0,,,45,8,PREGNANCY,NICOTINE,Nicotine replacement therapy during PREGNANCY.,9-21-29-36-0,0-9-21-29-36,NICOTINE replacement therapy during pregnancy.,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 07:39:42,1640144490,5/21/2015 07:38:42,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 07:52:25,1640151230,5/21/2015 07:52:15,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 07:59:43,1640155216,5/21/2015 07:59:28,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 08:01:12,1640155926,5/21/2015 08:00:51,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,36,0,,,45,8,PREGNANCY,NICOTINE,Nicotine replacement therapy during PREGNANCY.,9-21-29-36-0,0-9-21-29-36,NICOTINE replacement therapy during pregnancy.,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 08:10:07,1640160660,5/21/2015 08:09:53,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 08:27:14,1640170086,5/21/2015 08:26:56,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 08:30:07,1640171675,5/21/2015 08:29:50,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 09:14:21,1640194509,5/21/2015 09:14:10,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352584,5/21/2015 09:19:11,1640196793,5/21/2015 09:18:59,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724352585,5/21/2015 10:43:16,1640238100,5/21/2015 10:42:58,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 10:53:30,1640243614,5/21/2015 10:53:19,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 11:04:44,1640248794,5/21/2015 11:04:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 11:40:47,1640264536,5/21/2015 11:40:34,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,145,"AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 11:47:47,1640267819,5/21/2015 11:47:16,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,29,145,,,38,149,HEMOLYSIS,AIHA,"α - methyldopa - type AIHA, HEMOLYSIS usually ceases within 3 w<span id=""transmark""></span>k;",5-6-7-17-18-23-29-39-47-54-61-63,124-129-136-145-151-161-168-173-177-182-185-193-198-202,"With hapten mediated AIHA, hemolysis ceases when the drug is cleared from the pla<span id=""transmark""></span>sma.","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 12:38:10,1640290107,5/21/2015 12:37:45,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,29,145,,,38,149,HEMOLYSIS,AIHA,"HEMOLYSIS hapten mediated AIHA,",29-129-136-145,145-29,"hemolysis AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 12:44:11,1640292883,5/21/2015 12:43:55,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,29,145,,,38,149,HEMOLYSIS,AIHA,"methyldopa type AIHA, HEMOLYSIS usually ceases within 3 wk;",7-18-23-29-39-47-54-61-63,124-129-136-145-151-161-168-173-177-182-185-193-198-202,"With hapten mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 12:57:56,1640298552,5/21/2015 12:57:29,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,29,145,,,38,149,HEMOLYSIS,AIHA,"With α methyldopa type AIHA, HEMOLYSIS usually ceases within",5-7-18-23-29-39-47-54-0,129-136-145-151-161-168,"hapten mediated AIHA, hemolysis ceases when","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 13:02:09,1640300199,5/21/2015 13:01:18,false,instagc,1.0,15285653,USA,"","",172.162.76.35,29,145,,,38,149,HEMOLYSIS,AIHA,"methyldopa type AIHA, HEMOLYSIS usually ceases within 3 wk; however, a positive Coombs' test may persist for &gt; 1 yr. With hapten mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",7-18-23-29-39-47-54-61-63-67-76-78-87-95-100-104-112-116-118-120-124-129-136-145-151-161-168-173-177-182-185-193-198-202,124-129-136-145-151-161-168-173-177-182-185-193-198-202,"With hapten mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352585,5/21/2015 13:14:34,1640305552,5/21/2015 13:13:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,29,145,,,38,149,HEMOLYSIS,AIHA,"methyldopa type AIHA, HEMOLYSIS",7-18-23-29,145,"AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724352586,5/21/2015 12:45:19,1640293431,5/21/2015 12:44:58,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY forms of GSD,124-148-154-157,170-180-218-223-188,"lysosomal storage diseases, TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 12:50:58,1640295670,5/21/2015 12:50:40,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,124,218,,,136,225,HEPATOMEGALY,TYPE II,"Organomegaly may reflect a failure substrate degradation organ cells (eg, HEPATOMEGALY in hepatic forms",0-13-17-25-27-38-107-113-119-124-137-140-148-48,107-165-170-180-188-198-211-214-218-223-113,"organ cells many lysosomal storage diseases, cardiomegaly in GSD TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 13:18:10,1640307556,5/21/2015 13:17:06,false,instagc,1.0,15285653,USA,"","",172.162.76.35,124,218,,,136,225,HEPATOMEGALY,TYPE II,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",0-13-17-25-27-35-38-48-60-70-73-83-96-103-107-113-119-124-137-140-148-154-157-161-165-170-180-188-198-211-214-218-223,0-13-17-25-27-35-38-48-60-70-73-83-96-103-107-113-119-124-137-140-148-154-157-161-165-170-180-198-211-214-218-223-188,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 13:29:49,1640313542,5/21/2015 13:29:29,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 13:34:51,1640316157,5/21/2015 13:34:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,124,218,,,136,225,HEPATOMEGALY,TYPE II,organ cells HEPATOMEGALY in hepatic forms,107-113-124-137-140-148,198-211-214-218-223,cardiomegaly in GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 13:54:39,1640326108,5/21/2015 13:54:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 14:25:05,1640345197,5/21/2015 14:24:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 14:26:38,1640346210,5/21/2015 14:26:09,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,124,218,,,136,225,HEPATOMEGALY,TYPE II,"organ cells (eg, HEPATOMEGALY in hepatic forms GSD lysosomal storage diseases, cardiomegaly in GSD type II.",107-113-119-124-137-140-148-157-170-180-188-198-214-218-223-211,124-140-148-170-180-188-198-211-214-218-223-157,"hepatomegaly hepatic forms GSD lysosomal storage diseases, cardiomegaly in GSD TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 14:28:13,1640347086,5/21/2015 14:28:02,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352586,5/21/2015 14:28:43,1640347360,5/21/2015 14:28:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,124,218,,,136,225,HEPATOMEGALY,TYPE II,"organ cells (eg, HEPATOMEGALY in hepatic forms of GSD",107-113-119-124-137-140-148-157-154,165-170-180-198-211-214-218-223-188,"many lysosomal storage diseases, cardiomegaly in GSD TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724352587,5/21/2015 11:43:47,1640265959,5/21/2015 11:43:34,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,55,23,,,57,26,TB,PPD,TB,55,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 12:42:54,1640292379,5/21/2015 12:42:32,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,55,23,,,57,26,TB,PPD,PPD TB,55-23,23-43-55-58,PPD QuantiFERON TB Gold,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 12:48:31,1640294618,5/21/2015 12:48:08,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,55,23,,,57,26,TB,PPD,smear the QuantiFERON TB Gold was 35.4% smear/culture positive,39-43-55-58-63-67-187-201--1,4-16-19-23-31-35-63-67-73-77-84,"specificity of the PPD mm) and was 35.4% and 98.1%, respectively,","The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 13:12:23,1640304586,5/21/2015 13:10:33,false,instagc,1.0,15285653,USA,"","",172.162.76.35,55,23,,,57,26,TB,PPD,"smear and the QuantiFERON TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive",35-39-43-55-58-63-67-73-77-84-98-102-106-118-122-128-132-136-140-144-148-161-175-184-187-201--1,4-16-19-23-27-31-35-39-43-55-58-63-67-73-77-84-98-102-106-118-122-128-132-136-140-144-148-161-175-184-187-201--1,"smear specificity of the PPD (10 mm) and the QuantiFERON TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive","The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 13:26:23,1640311826,5/21/2015 13:25:57,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 13:31:42,1640314499,5/21/2015 13:31:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,55,23,,,57,26,TB,PPD,the QuantiFERON TB Gold was 35.4%,39-43-55-58-63-67,4-16-19-23,specificity of the PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 13:52:44,1640325077,5/21/2015 13:52:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 14:10:17,1640335749,5/21/2015 14:08:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23-27-31,PPD (10 mm),"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 14:20:55,1640342567,5/21/2015 14:20:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,55-58-43,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352587,5/21/2015 14:21:55,1640343122,5/21/2015 14:21:06,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,55,23,,,57,26,TB,PPD,PPD mm) QuantiFERON TB Gold,23-31-43-55-58,4-16-19-23-31-43-55-58,specificity of the PPD mm) QuantiFERON TB Gold,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724352588,5/21/2015 10:43:54,1640238447,5/21/2015 10:43:33,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,44,2,,,48,14,PAIN,FIBROMYALGIA,widespread PAIN,33-44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 11:41:17,1640264764,5/21/2015 11:41:05,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 11:49:50,1640268715,5/21/2015 11:48:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,44,2,,,48,14,PAIN,FIBROMYALGIA,"widesp<span id=""transmark""></span>read PAIN and multiple tender points,",44-49-53-62-69-33,2-16-30-33-44-49-53-62-69,"FIBROMYALGIA, characterized by widespread pain and multiple tender po<span id=""transmark""></span>ints,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 12:38:52,1640290497,5/21/2015 12:38:35,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,44,2,,,48,14,PAIN,FIBROMYALGIA,"Fibromyalgia, PAIN",44-2,2-33-44,"FIBROMYALGIA, widespread pain","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 12:44:48,1640293101,5/21/2015 12:44:25,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,44,2,,,48,14,PAIN,FIBROMYALGIA,"Fibromyalgia, characterized by widespread PAIN and multiple tender points, most commonly seen in the 40 to 60 age group.",2-16-30-33-44-49-53-62-69-129-134-143-148-151-155-158-161-168-164,0-2-16-30-33-44-49-53-62-69,"• FIBROMYALGIA, characterized by widespread pain and multiple tender points,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 12:59:04,1640298984,5/21/2015 12:58:23,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,44,2,,,48,14,PAIN,FIBROMYALGIA,"characterized by widespread PAIN and multiple tender points,",16-30-33-44-49-53-62-69,0-2-16-30-33-44-49-53-62-69,"• FIBROMYALGIA, characterized by widespread pain and multiple tender points,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 13:03:34,1640300792,5/21/2015 13:02:35,false,instagc,1.0,15285653,USA,"","",172.162.76.35,44,2,,,48,14,PAIN,FIBROMYALGIA,"characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",16-30-33-44-49-53-62-69-77-84-91-97-103-108-111-115-122-126-129-134-143-148-151-155-158-161-164-168,0-2-16-30-33-44-49-53-62-69-77-84-91-97-103-108-111-115-122-126-129-134-143-148-151-155-158-161-164-168,"• FIBROMYALGIA, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 13:15:54,1640306485,5/21/2015 13:15:17,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 13:21:16,1640309251,5/21/2015 13:20:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352588,5/21/2015 13:26:17,1640311796,5/21/2015 13:25:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,44,2,,,48,14,PAIN,FIBROMYALGIA,"characterized by widespread PAIN and multiple tender points,",16-30-33-44-49-53-62-69,2-16,"FIBROMYALGIA, characterized","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724352589,5/21/2015 07:52:23,1640151207,5/21/2015 07:51:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 07:57:13,1640153885,5/21/2015 07:56:56,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 08:04:23,1640157614,5/21/2015 08:04:09,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 08:13:55,1640162700,5/21/2015 08:13:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 08:31:28,1640172363,5/21/2015 08:31:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 08:34:48,1640174227,5/21/2015 08:34:34,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121-128,IRON deficiency anemia from,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 09:18:37,1640196539,5/21/2015 09:18:21,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105,IRON,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 09:23:19,1640198748,5/21/2015 09:23:01,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 09:27:55,1640201095,5/21/2015 09:27:42,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,DEFICIENCY ANEMIAS.,142-153,105,IRON,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352589,5/21/2015 09:29:16,1640201855,5/21/2015 09:29:05,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,137-142-153-133,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724352590,5/21/2015 11:44:01,1640266068,5/21/2015 11:43:48,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 12:43:09,1640292471,5/21/2015 12:42:55,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome PAIN.,0-8-17-77-22,0-8-17-22-77,COMPLEX REGIONAL PAIN SYNDROME pain.,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 12:48:43,1640294680,5/21/2015 12:48:32,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained PAIN.,0-8-17-22-41-50-66-77-31,0-8-17-22-31-41-50-66-77,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained pain.,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 13:12:55,1640304836,5/21/2015 13:12:24,false,instagc,1.0,15285653,USA,"","",172.162.76.35,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained PAIN.,0-8-17-22-41-50-66-77-31,0-8-17-22-31-41-50-66-77,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained pain.,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 13:26:57,1640312058,5/21/2015 13:26:24,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,sympathetically maintained PAIN.,66-77-50,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 13:32:03,1640314702,5/21/2015 13:31:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,involves sympathetically maintained PAIN.,41-50-66-77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 13:52:57,1640325171,5/21/2015 13:52:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 14:12:47,1640337374,5/21/2015 14:10:19,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,maintained PAIN.,66-77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 14:21:41,1640342971,5/21/2015 14:20:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352590,5/21/2015 14:22:21,1640343351,5/21/2015 14:21:57,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,sympathetically maintained PAIN.,50-66-77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724352591,5/21/2015 07:23:35,1640136040,5/21/2015 07:22:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of HYPOGLYCEMIA.,2-13-20-23-26-30-39-46-56-65-75-79-89-92-68,2-13-20-23-26-30-39-46-56-65-68-75-79-89-92,Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of hypoglycemia.,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 07:38:08,1640143713,5/21/2015 07:37:27,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,20-23-26-30-39-46-56,5% or 10% DEXTROSE during quinidine infusion,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 07:51:51,1640150959,5/21/2015 07:51:37,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 07:59:01,1640154788,5/21/2015 07:58:41,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 08:00:32,1640155556,5/21/2015 08:00:22,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,quinidine the incidence of HYPOGLYCEMIA.,75-79-89-92-46,2-20-23-26-30-39-46-56-79-92,Administer 5% or 10% DEXTROSE during quinidine infusion incidence hypoglycemia.,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 08:09:36,1640160406,5/21/2015 08:09:20,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 08:26:33,1640169737,5/21/2015 08:26:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 08:29:19,1640171158,5/21/2015 08:28:57,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 09:07:28,1640190824,5/21/2015 09:07:20,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,20-23-26-30,5% or 10% DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352591,5/21/2015 09:13:47,1640194205,5/21/2015 09:13:34,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724352592,5/21/2015 09:25:34,1640199849,5/21/2015 09:25:22,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE is a rare,0-11-27-37-45-48-50,72-79-82-86-97-108,caused by the BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 09:30:26,1640202500,5/21/2015 09:30:13,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86,BACTERIUM,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 09:31:23,1640202910,5/21/2015 09:31:07,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-27-37-11,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 09:54:13,1640213957,5/21/2015 09:53:57,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:10:27,1640222177,5/21/2015 10:10:04,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-11-27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:20:22,1640227159,5/21/2015 10:20:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-11-27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:29:11,1640231075,5/21/2015 10:27:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-11-27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:34:03,1640233386,5/21/2015 10:33:50,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-11-27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:34:09,1640233451,5/21/2015 10:33:40,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352592,5/21/2015 10:46:19,1640239762,5/21/2015 10:46:03,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724352593,5/21/2015 09:25:49,1640200006,5/21/2015 09:25:35,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 09:30:44,1640202618,5/21/2015 09:30:28,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 09:31:39,1640203060,5/21/2015 09:31:26,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,58-63-76-79,drug susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 09:54:51,1640214294,5/21/2015 09:54:13,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:11:09,1640222529,5/21/2015 10:10:29,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB caused by drug susceptible M. tuberculosis,38-45-48-55-58-63-76-79,38-45-55-58-63-76-79-48,active TB caused by drug susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:20:38,1640227256,5/21/2015 10:20:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,58-62-63-76-79,drug - susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:30:16,1640231575,5/21/2015 10:29:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,58-63-76-79,drug susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:34:14,1640233478,5/21/2015 10:34:03,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,45,76,,,47,91,TB,M. TUBERCULOSIS,treatment of active TB,25-35-38-45,76-79-94-106-115,M. TUBERCULOSIS recommended multiple drug,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:34:33,1640233601,5/21/2015 10:34:10,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352593,5/21/2015 10:46:34,1640239853,5/21/2015 10:46:20,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,58-63-76-79,drug susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724352594,5/21/2015 10:01:54,1640217945,5/21/2015 10:01:31,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"HEADACHE,",172,138-147-151-159,MIGRAINE and chronic tension,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 10:28:18,1640230645,5/21/2015 10:27:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension - type HEADACHE,",151-159-166-167-172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 10:41:25,1640237102,5/21/2015 10:40:29,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147-151-159-167-172,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 10:52:04,1640242866,5/21/2015 10:51:50,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 10:58:55,1640246262,5/21/2015 10:58:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 11:34:44,1640261623,5/21/2015 11:33:34,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147-151-159-167-172,"MIGRAINE and chronic tension type headac<span id=""transmark""></span>he,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 11:39:15,1640263849,5/21/2015 11:38:56,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"HEADACHE,",172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 12:34:47,1640288649,5/21/2015 12:34:20,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"migraine HEADACHE,",172-138,138-147-172,"MIGRAINE and headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 12:41:57,1640291955,5/21/2015 12:41:24,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE, which each account for about 50% of those with CDH,",151-159-167-172-182-188-193-201-205-211-215-218-224-229,0-9-113-122-125-138-147-151-159-167-73,"HEADACHE TYPES includes chronic, or transformed, MIGRAINE and chronic tension type","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352594,5/21/2015 12:54:36,1640297162,5/21/2015 12:53:52,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE, which each account",151-159-167-172-182-188-193,113-122-125-138-147-151-159-167,"chronic, or transformed, MIGRAINE and chronic tension type","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724352595,5/21/2015 13:22:57,1640309961,5/21/2015 13:21:57,false,instagc,1.0,15285653,USA,"","",172.162.76.35,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,Intensive replacement of basal insulin in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,0-10-22-25-31-39-42-51-56-61-63-72-81-86-92-99-107-114-117-127-129-131-137-148-156-171-174-178-186-191-197-203-207-216-224-227-234-237,0-10-22-25-31-39-42-51-56-61-63-72-81-86-92-99-107-114-117-127-129-131-137-148-156-171-174-178-186-191-197-203-207-216-224-227-234-237,Intensive replacement of basal INSULIN in patients with type 1 diabetes mellitus give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 13:32:32,1640314853,5/21/2015 13:32:12,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 13:38:43,1640317950,5/21/2015 13:37:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,10-22-25-31,replacement of basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 13:56:19,1640327239,5/21/2015 13:55:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,31,INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 14:28:24,1640347177,5/21/2015 14:28:01,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 14:29:58,1640348363,5/21/2015 14:29:34,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 14:31:03,1640348948,5/21/2015 14:30:23,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS glargine insulin,56-61-63-72-207-216,25-31-39-42-51-56-61-63-72,basal INSULIN in patients with type 1 diabetes mellitus,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 14:45:59,1640358020,5/21/2015 14:45:46,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime:,39-42-51-56-61-63-72-81-86-92-99-107-114-117,10-22-25-31-39-42-51-56-61-63-72,replacement of basal INSULIN in patients with type 1 diabetes mellitus,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 15:04:57,1640368247,5/21/2015 15:04:45,false,clixsense,1,6574449,USA,"","",216.216.68.85,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352595,5/21/2015 15:06:56,1640369486,5/21/2015 15:06:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724352596,5/21/2015 09:21:12,1640197696,5/21/2015 09:20:53,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 09:25:19,1640199714,5/21/2015 09:25:06,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 09:30:13,1640202300,5/21/2015 09:30:00,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 09:31:06,1640202779,5/21/2015 09:30:56,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 09:51:41,1640212775,5/21/2015 09:51:30,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 09:53:56,1640213861,5/21/2015 09:53:36,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 10:10:03,1640222047,5/21/2015 10:09:33,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 10:20:10,1640227076,5/21/2015 10:19:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 10:27:19,1640230165,5/21/2015 10:26:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352596,5/21/2015 10:33:49,1640233232,5/21/2015 10:33:33,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,for AIDS CRYPTOCOCCAL MENINGITIS.,109-113-129-142,51-54-74-89-101,of itraconazole FLUCONAZOLE maintenance therapy,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724352597,5/21/2015 11:44:18,1640266228,5/21/2015 11:44:03,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 12:43:33,1640292627,5/21/2015 12:43:10,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, FLUORESCENT TREPONEMAL ANTIBODY",34-63-75-86-44,63-75-86-95-151-161-106,fluorescent treponemal antibody absorption test TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 12:49:16,1640294901,5/21/2015 12:48:44,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"all patients should have serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY absorption test",9-13-22-29-34-44-53-63-75-86-95-106,9-13-22-29-34-44-118-140-146-151-161-172-177-184-53,"all patients should have serologic testing, including microhemagglutination assay for TREPONEMA PALLIDUM Lyme titer, and","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 13:13:26,1640305087,5/21/2015 13:12:56,false,instagc,1.0,15285653,USA,"","",172.162.76.35,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY absorption test or the microhemagglutination assay for Treponema pallidum Lyme titer, and Epstein Barr panel.",34-44-53-63-75-86-95-106-111-114-118-140-146-151-161-172-177-184-188-196-201,53-63-75-86-95-106-111-114-118-140-146-151-161-172-177-184-188-196-201,"including fluorescent treponemal antibody absorption test or the microhemagglutination assay for TREPONEMA PALLIDUM Lyme titer, and Epstein Barr panel.","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 13:27:31,1640312313,5/21/2015 13:26:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY absorption test,63-75-86-95-106,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 13:32:57,1640315044,5/21/2015 13:32:05,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY",34-44-53-63-75-86,118-140-146-151-161,microhemagglutination assay for TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 13:53:13,1640325317,5/21/2015 13:52:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 14:22:05,1640343206,5/21/2015 14:21:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 14:23:17,1640343926,5/21/2015 14:22:22,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic including FLUORESCENT TREPONEMAL ANTIBODY absorption test microhemagglutination assay Treponema pallidum Lyme titer, Epstein Barr panel.",34-53-63-75-86-95-106-118-140-151-161-172-177-188-196-201,75-118-140-146-151-161-172-177-184-196-201-86,"treponemal antibody microhemagglutination assay for TREPONEMA PALLIDUM Lyme titer, and Barr panel.","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352597,5/21/2015 14:24:47,1640345028,5/21/2015 14:24:31,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724352598,5/21/2015 07:21:30,1640134847,5/21/2015 07:21:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,56,89,,,66,97,ORNITHOSIS,PSITTACI,Chlamydial Infections Treatment of psittacosis + (ORNITHOSIS) caused by Chlamydia psittaci.,0-11-23-33-36-50-55-68-75-79-89,0-11-23-33-36-50-68-75-79-89-55,Chlamydial Infections Treatment of psittacosis + (ornithosis) caused by Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 07:34:41,1640141756,5/21/2015 07:33:16,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 07:50:12,1640149924,5/21/2015 07:49:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,56,89,,,66,97,ORNITHOSIS,PSITTACI,psittacosis + (ORNITHOSIS) caused by Chlamydia,36-50-55-68-75-79,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 07:57:33,1640154036,5/21/2015 07:57:07,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 07:59:33,1640155101,5/21/2015 07:59:19,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,56,89,,,66,97,ORNITHOSIS,PSITTACI,Chlamydial psittacosis + (ORNITHOSIS) caused by Chlamydia,36-50-55-68-75-79-0,0-36-68-75-79-89-55,Chlamydial psittacosis (ornithosis) caused by Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 08:08:24,1640159820,5/21/2015 08:08:01,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 08:25:09,1640168952,5/21/2015 08:24:46,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 08:27:31,1640170243,5/21/2015 08:26:52,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,75-89,by PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 09:06:36,1640190266,5/21/2015 09:06:23,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352598,5/21/2015 09:12:12,1640193286,5/21/2015 09:11:19,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724352599,5/21/2015 07:51:16,1640150579,5/21/2015 07:50:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 07:56:54,1640153769,5/21/2015 07:56:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352-365,DIAZEPAM phenytoin,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 08:04:08,1640157433,5/21/2015 08:03:07,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352-361-365,DIAZEPAM and phenytoin,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 08:13:39,1640162554,5/21/2015 08:13:16,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 08:31:12,1640172200,5/21/2015 08:30:51,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,122-129-116,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 08:34:33,1640174098,5/21/2015 08:34:10,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 09:18:19,1640196416,5/21/2015 09:17:57,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 09:23:00,1640198625,5/21/2015 09:22:36,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 09:27:41,1640200967,5/21/2015 09:27:26,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352599,5/21/2015 09:29:04,1640201762,5/21/2015 09:28:28,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724352600,5/21/2015 08:14:20,1640162845,5/21/2015 08:13:57,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,32-46-58,Uncomplicated CHLOROQUINE resistant,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 08:32:01,1640172703,5/21/2015 08:31:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,46-58-71-68,CHLOROQUINE resistant P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:19:04,1640196769,5/21/2015 09:18:40,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,82,46,,,89,57,MALARIA,CHLOROQUINE,falciparum MALARIA,71-82,46,CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:23:37,1640198853,5/21/2015 09:23:20,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,82,46,,,89,57,MALARIA,CHLOROQUINE,resistant P. falciparum MALARIA,58-68-71-82,32-46,Uncomplicated CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:28:30,1640201379,5/21/2015 09:27:56,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,46,CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:29:32,1640201948,5/21/2015 09:29:18,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,82,46,,,89,57,MALARIA,CHLOROQUINE,P. falciparum MALARIA,68-71-82,32-46-58-68-71,Uncomplicated CHLOROQUINE resistant P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:50:21,1640212122,5/21/2015 09:49:45,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,46,CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 09:51:20,1640212637,5/21/2015 09:50:21,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,82,46,,,89,57,MALARIA,CHLOROQUINE,Chloroquine resistant P. falciparum MALARIA,46-58-68-71-82,46-58-68-71-82,CHLOROQUINE resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 10:07:03,1640220477,5/21/2015 10:05:21,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,82,46,,,89,57,MALARIA,CHLOROQUINE,Chloroquine resistant P. falciparum MALARIA,58-68-71-82-46,46-58-68-71-82,CHLOROQUINE resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352600,5/21/2015 10:17:00,1640225331,5/21/2015 10:16:20,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,82,46,,,89,57,MALARIA,CHLOROQUINE,P. falciparum MALARIA,68-71-82,32-46-57-58-68-71-82,Uncomplicated CHLOROQUINE - resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724352601,5/21/2015 12:45:37,1640293510,5/21/2015 12:45:20,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,55,96,,,62,103,DISEASE,VIRUS,DISEASE Hanta virus,55-73-79,43-49-55-96-33,arthropod borne viral disease VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 12:51:18,1640295812,5/21/2015 12:50:59,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,55,96,,,62,103,DISEASE,VIRUS,fever with renal syndrome An arthropod borne viral DISEASE caused by Hanta virus,0-6-11-17-30-33-43-49-55-63-70-73-79,30-33-43-49-55-63-73-79-85-88-96-70,An arthropod borne viral disease caused by Hanta virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 13:18:54,1640307915,5/21/2015 13:18:11,false,instagc,1.0,15285653,USA,"","",172.162.76.35,55,96,,,62,103,DISEASE,VIRUS,An arthropod borne viral DISEASE caused by Hanta virus or related viruses.,30-33-43-49-55-63-70-73-79-85-88-96,30-33-43-49-55-63-70-79-85-88-96-73,An arthropod borne viral disease caused by Hanta virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 13:30:14,1640313727,5/21/2015 13:29:50,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,79-96-73,Hanta virus VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 13:35:07,1640316279,5/21/2015 13:34:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,55,96,,,62,103,DISEASE,VIRUS,borne viral DISEASE caused by Hanta virus,43-49-55-63-70-73-79,79-85-88-96,virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 13:54:52,1640326251,5/21/2015 13:54:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 14:25:30,1640345471,5/21/2015 14:25:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,55,96,,,62,103,DISEASE,VIRUS,arthropod - borne viral DISEASE,33-43-49-55-42,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 14:27:03,1640346424,5/21/2015 14:26:40,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,55,96,,,62,103,DISEASE,VIRUS,renal syndrome An arthropod borne viral DISEASE caused by Hanta virus,17-30-33-43-49-55-63-70-73-79-11,79-85-88-96-73,Hanta virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 14:28:29,1640347225,5/21/2015 14:28:16,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352601,5/21/2015 14:28:56,1640347522,5/21/2015 14:28:44,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,55,96,,,62,103,DISEASE,VIRUS,An arthropod borne viral DISEASE caused by Hanta virus or related viruses.,30-33-43-49-55-63-70-73-79-85-88-96,79-85-88-96-73,Hanta virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724352602,5/21/2015 11:41:58,1640265032,5/21/2015 11:41:45,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 11:54:16,1640270787,5/21/2015 11:51:21,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,93,115,,,97,128,HFR,PUUMALA VIRUS,hantaviruses causing HFRS,72-85-93,102-108-115-123-130-134-142-151,"Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade vir<span id=""transmark""></span>us.","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 12:40:04,1640291137,5/21/2015 12:39:36,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,93,115,,,97,128,HFR,PUUMALA VIRUS,"HFRS Seoul virus, Puumala virus, Dobrava Belgrade virus.",93-102-108-115-123-134-142-151,115-123-93,"HFRS PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 12:45:35,1640293492,5/21/2015 12:45:21,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,93,115,,,97,128,HFR,PUUMALA VIRUS,"Hemorrhagic fever other hantaviruses causing HFRS are Seoul virus,",0-66-72-85-93-98-102-108-12,98-102-108-115-123-130-134-142-93,"HFRS are Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:00:42,1640299659,5/21/2015 13:00:16,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,93,115,,,97,128,HFR,PUUMALA VIRUS,"hantaviruses causing HFRS are Seoul virus,",72-85-93-98-102-108,93-98-102-108-115-123-142,"HFRS are Seoul virus, PUUMALA VIRUS, Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:05:41,1640301738,5/21/2015 13:05:16,false,instagc,1.0,15285653,USA,"","",172.162.76.35,93,115,,,97,128,HFR,PUUMALA VIRUS,"other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava Belgrade virus.",66-72-85-93-98-102-108-115-123-130-134-142-151,0-12-18-23-29-40-46-51-59-66-72-85-93-98-102-108-115-123-130-134-142-151,"Hemorrhagic fever with renal syndrome Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade virus.","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:22:49,1640309893,5/21/2015 13:22:21,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:28:35,1640312838,5/21/2015 13:28:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,93,115,,,97,128,HFR,PUUMALA VIRUS,hantaviruses causing HFRS,72-85-93,102-108-115-123-130-134-142,"Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:44:20,1640320691,5/21/2015 13:43:46,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,102-108-115-123-130-134-142,"Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352602,5/21/2015 13:46:28,1640321832,5/21/2015 13:46:21,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,93,115,,,97,128,HFR,PUUMALA VIRUS,"other hantaviruses causing HFRS are Seoul virus,",66-72-85-93-98-102-108,98-102-108-115-123-130-134-142,"are Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724352603,5/21/2015 13:58:13,1640328347,5/21/2015 13:57:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 14:31:27,1640349290,5/21/2015 14:30:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 14:34:45,1640351320,5/21/2015 14:34:17,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,"conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, large granular lymphocytic leukemia.",6-17-22-28-41-49-61-77-87-93-103-124-130-139-151,77-87-93-103-120-124-130-151,"syndrome, acute leukemia, MEGALOBLASTOSIS, and large granular leukemia.","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 14:47:54,1640359197,5/21/2015 14:47:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome,",0-6-17-22-28-41-49-61-77,77-87-93-103-120-124-130,"syndrome, acute leukemia, MEGALOBLASTOSIS, and large granular","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 15:13:47,1640373565,5/21/2015 15:13:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 15:33:40,1640384050,5/21/2015 15:33:28,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 15:57:13,1640399043,5/21/2015 15:56:43,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,87-103-93,"acute leukemia, MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 16:11:25,1640407744,5/21/2015 16:10:43,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,93-103,"leukemia, MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 16:15:43,1640410432,5/21/2015 16:15:32,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352603,5/21/2015 16:18:21,1640412094,5/21/2015 16:18:12,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724352604,5/21/2015 11:43:19,1640265735,5/21/2015 11:43:06,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 12:15:31,1640280004,5/21/2015 12:14:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,37,21,,,41,24,PAIN,RSD,Pain in RSD is regional PAIN;,13-18-21-25-28-37,13-18-21-25-28-37,Pain in RSD is regional pain;,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 12:42:10,1640292097,5/21/2015 12:41:48,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,37,21,,,41,24,PAIN,RSD,PAIN; radicular pain syndromes.,37-132-142-147,21-28-37,RSD regional pain;,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 12:47:41,1640294277,5/21/2015 12:47:23,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,37,21,,,41,24,PAIN,RSD,"Pain in RSD is regional PAIN; it does not respect root or nerve territories,",13-18-21-25-28-37-43-46-51-55-63-68-71-77,11-13-18-21-25-28-37-46-51-55-63-68-71-77,"• Pain in RSD is regional pain; does not respect root or nerve territories,","Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 13:09:40,1640303344,5/21/2015 13:09:00,false,instagc,1.0,15285653,USA,"","",172.162.76.35,37,21,,,41,24,PAIN,RSD,"RSD is regional PAIN; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",21-25-28-37-43-46-51-55-63-68-71-77-90-105-108-113-128-132-142-147,11-13-18-21-25-28-37-43-46-51-55-63-68-71-77-90-105-108-113-128-132-142-147,"• Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.","Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 13:25:36,1640311435,5/21/2015 13:25:15,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,37,21,,,41,24,PAIN,RSD,regional PAIN;,28-37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 13:31:02,1640314114,5/21/2015 13:30:36,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,37,21,,,41,24,PAIN,RSD,RSD is regional PAIN;,21-25-28-37,21-25-28-37,RSD is regional pain;,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 13:52:11,1640324821,5/21/2015 13:51:44,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 14:08:28,1640334783,5/21/2015 14:07:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,37,21,,,41,24,PAIN,RSD,RSD is regional PAIN;,21-25-28-37,11-13-18-21-25-28-37,• Pain in RSD is regional pain;,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352604,5/21/2015 14:20:12,1640342269,5/21/2015 14:18:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724352605,5/21/2015 12:44:57,1640293189,5/21/2015 12:44:41,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,Transdermal clonidine HYPERTENSION.,29-138-41,29-104-41,Transdermal clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 12:50:39,1640295517,5/21/2015 12:50:21,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate HYPERTENSION.,29-41-51-55-60-73-85-89-94-104-121-126-129-138-118,85-89-94-104-118-121-126-129-138,for oral clonidine HYDROCHLORIDE in mild to moderate hypertension.,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 13:17:04,1640307089,5/21/2015 13:16:12,false,instagc,1.0,15285653,USA,"","",172.162.76.35,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,106 110 115 118 Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate HYPERTENSION.,0-8-16-24-29-41-51-55-60-73-85-89-94-104-121-126-129-138-118,0-8-16-24-29-41-51-55-60-73-85-89-94-104-118-121-126-129-138,106 110 115 118 Transdermal clonidine has been successfully substituted for oral clonidine HYDROCHLORIDE in mild to moderate hypertension.,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 13:29:28,1640313377,5/21/2015 13:29:07,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,94-104,clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 13:34:33,1640315952,5/21/2015 13:34:22,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild to moderate HYPERTENSION.,121-126-129-138,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 13:54:23,1640325942,5/21/2015 13:54:09,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,94-104,clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 14:24:53,1640345084,5/21/2015 14:24:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,94-104,clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 14:26:07,1640345835,5/21/2015 14:25:37,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild to moderate HYPERTENSION.,121-126-129-138,85-89-94-104,for oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 14:27:59,1640346983,5/21/2015 14:27:40,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352605,5/21/2015 14:28:26,1640347195,5/21/2015 14:28:10,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild to moderate HYPERTENSION.,121-126-129-138,85-89-94-104-118-121-126-129-138,for oral clonidine HYDROCHLORIDE in mild to moderate hypertension.,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724352606,5/21/2015 09:20:12,1640197260,5/21/2015 09:19:53,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,clinically significant HEMORRHAGE,52-63-75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 09:24:20,1640199145,5/21/2015 09:24:08,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 09:29:28,1640201933,5/21/2015 09:29:14,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 09:30:27,1640202505,5/21/2015 09:30:10,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,"HEMORRHAGE thrombosis,",75-89,13-18-28,with ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 09:51:01,1640212456,5/21/2015 09:50:50,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 09:52:46,1640213215,5/21/2015 09:52:12,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 10:08:43,1640221319,5/21/2015 10:08:17,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 10:18:02,1640225938,5/21/2015 10:17:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,"clinically significant HEMORRHAGE or thrombosis,",52-63-75-86-89,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 10:23:11,1640228448,5/21/2015 10:21:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352606,5/21/2015 10:32:44,1640232752,5/21/2015 10:32:22,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724352607,5/21/2015 13:58:40,1640328671,5/21/2015 13:58:17,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,0-12,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 14:33:06,1640350090,5/21/2015 14:31:29,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,12-0,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 14:35:35,1640351768,5/21/2015 14:34:47,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH luteinizing hormone MPA medroxyprogesterone acetate PE pulmonary embolism PID pelvic inflammatory disease progestin,0-12-23-31-37-49-58-65-85-112-118-128-138-145-152-165-181,0-12-23-31-37-49-58-65-85-94-100-105-112-116-118-128-138,lactational amenorrhea method LH luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE OR odds ratio PE  pulmonary embolism PID,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 14:48:17,1640359314,5/21/2015 14:47:55,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH luteinizing hormone MPA medroxyprogesterone acetate OR odds ratio PE,0-12-23-31-37-49-58-65-85-94-100-105-112,37-49-58-65-85-94-100-105-112,luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE OR odds ratio PE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 15:16:01,1640374916,5/21/2015 15:13:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method,0-12-23,65-85-94,MEDROXYPROGESTERONE ACETATE OR,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 15:33:58,1640384232,5/21/2015 15:33:42,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,AMENORRHEA,12,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 15:57:26,1640399176,5/21/2015 15:57:15,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,AMENORRHEA,12,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 16:12:20,1640408190,5/21/2015 16:11:26,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH,0-12-23-31,65-85-94-100-105-112,MEDROXYPROGESTERONE ACETATE OR odds ratio PE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 16:15:56,1640410672,5/21/2015 16:15:46,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH,0-12-23-31,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352607,5/21/2015 16:27:50,1640418622,5/21/2015 16:27:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH,0-12-23-31,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724352608,5/21/2015 09:33:17,1640203866,5/21/2015 09:33:03,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,THROMBOSIS,96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 09:58:34,1640216269,5/21/2015 09:58:18,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,THROMBOSIS,96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:24:59,1640229205,5/21/2015 10:24:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:36:23,1640234445,5/21/2015 10:36:09,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS in elective cancer,86-91-96-107-110-119,27-38-45-60,ENOXAPARIN versus unfractionated heparin,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:37:51,1640235286,5/21/2015 10:37:35,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:49:43,1640241674,5/21/2015 10:49:27,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:53:34,1640243632,5/21/2015 10:52:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 10:57:07,1640245313,5/21/2015 10:56:30,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,enoxaparin of deep vein THROMBOSIS in elective cancer,83-86-91-96-107-110-119-27,27-38-45-60,ENOXAPARIN versus unfractionated heparin,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 11:19:49,1640255260,5/21/2015 11:19:09,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,13-17-24-27-38-45-60-4,"Effic<span id=""transmark""></span>acy and safety of ENOXAPARIN versus unfractionated heparin",1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352608,5/21/2015 11:37:12,1640262728,5/21/2015 11:36:55,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,THROMBOSIS,96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724352609,5/21/2015 11:43:33,1640265853,5/21/2015 11:43:20,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,64,132,,,70,141,STONE,PHOSPHATE,STONES,64,132,PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 12:16:35,1640280476,5/21/2015 12:15:32,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,64,132,,,70,141,STONE,PHOSPHATE,"calcium STONES are composed mostly of calcium ox<span id=""transmark""></span>alate;",56-64-71-75-84-91-94-102,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 12:42:32,1640292245,5/21/2015 12:42:10,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,64,132,,,70,141,STONE,PHOSPHATE,STONES calcium oxalate;,64-94-102,56-64-132,calcium stones PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 12:48:07,1640294460,5/21/2015 12:47:42,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,64,132,,,70,141,STONE,PHOSPHATE,"80% of stones contain calcium, about 80% of calcium STONES are composed mostly of calcium oxalate;",8-12-15-22-30-43-49-53-56-64-71-75-84-91-94-102,8-12-15-22-115-120-124-132-30,"80% of stones contain calcium, rest are calcium PHOSPHATE.","• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 13:10:32,1640303728,5/21/2015 13:09:41,false,instagc,1.0,15285653,USA,"","",172.162.76.35,64,132,,,70,141,STONE,PHOSPHATE,"About 80% of stones contain calcium, and about 80% of calcium STONES are composed mostly of calcium oxalate; the rest are calcium phosphate.",2-8-12-15-22-30-39-43-49-53-56-64-71-75-84-91-94-102-111-115-120-124-132,2-8-12-15-22-30-39-43-49-53-56-64-71-75-84-91-94-102-115-120-124-132-111,"About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium PHOSPHATE.","• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 13:25:56,1640311617,5/21/2015 13:25:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 13:31:14,1640314200,5/21/2015 13:31:03,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,64,132,,,70,141,STONE,PHOSPHATE,80% of calcium STONES are composed,49-53-56-64-71-75,115-120-124-132,rest are calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 13:52:29,1640324969,5/21/2015 13:52:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 14:08:47,1640334953,5/21/2015 14:08:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352609,5/21/2015 14:21:04,1640342654,5/21/2015 14:20:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES calcium oxalate; calcium phosphate.,56-64-94-124-132-102,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724352610,5/21/2015 07:20:06,1640134223,5/21/2015 07:19:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"Sensitivity Reactions Hypersensitivity Reactions Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME, erythema multiforme.",0-12-23-40-51-59-69-80-90-98-106-141-150,0-12-23-40-51-59-69-80-90-98-106-141-150,"Sensitivity Reactions HYPERSENSITIVITY REACTIONS Serious cutaneous reactions, including Stevens Johnson syndrome, erythema multiforme.","Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 07:31:45,1640140366,5/21/2015 07:30:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 07:49:10,1640149402,5/21/2015 07:48:15,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 07:56:16,1640153457,5/21/2015 07:55:52,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 07:58:24,1640154467,5/21/2015 07:58:08,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"Reactions cutaneous reactions, including STEVENS JOHNSON SYNDROME, 1 2 93 erythema multiforme.",12-59-69-80-90-98-106-117-123-129-141-150,0-12-23-40-51-59-69-141,"Sensitivity Reactions HYPERSENSITIVITY REACTIONS Serious cutaneous reactions, erythema","Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 08:07:12,1640159098,5/21/2015 08:06:52,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 08:24:03,1640168375,5/21/2015 08:23:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 08:25:43,1640169266,5/21/2015 08:25:10,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 09:05:55,1640190025,5/21/2015 09:05:39,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352610,5/21/2015 09:10:31,1640192423,5/21/2015 09:10:05,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724352611,5/21/2015 07:48:25,1640148974,5/21/2015 07:47:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 07:55:41,1640153188,5/21/2015 07:55:27,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 08:02:25,1640156468,5/21/2015 08:02:09,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 08:12:39,1640162044,5/21/2015 08:12:26,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,treatment of BLASTOMYCOSIS.,120-130-133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 08:30:09,1640171672,5/21/2015 08:29:53,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 08:33:33,1640173631,5/21/2015 08:33:12,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 09:17:23,1640196031,5/21/2015 09:17:06,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 09:22:10,1640198109,5/21/2015 09:21:55,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 09:26:40,1640200446,5/21/2015 09:26:26,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352611,5/21/2015 09:27:46,1640201004,5/21/2015 09:27:23,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724352612,5/21/2015 10:03:08,1640218601,5/21/2015 10:02:53,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53,STAPHYLOCOCCUS,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 10:29:26,1640231201,5/21/2015 10:29:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,35-41-42-43-53-68,toxin 1 - producing STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 10:42:23,1640237669,5/21/2015 10:42:02,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 10:52:48,1640243156,5/21/2015 10:52:34,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 11:02:10,1640247711,5/21/2015 11:00:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 11:37:35,1640262987,5/21/2015 11:36:48,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME toxin,14-20-26-35,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 11:40:03,1640264192,5/21/2015 11:39:50,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53,STAPHYLOCOCCUS,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 12:36:54,1640289550,5/21/2015 12:36:31,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME Staphylococcus aureus,14-20-26-53-68,20-26-53-14,toxic shock syndrome STAPHYLOCOCCUS,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 12:43:04,1640292411,5/21/2015 12:42:39,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,Prevalence of TOXIC SHOCK SYNDROME toxin 1 producing Staphylococcus aureus in menstruating women.,0-11-14-20-26-35-41-43-53-68-127-130-143,35-41-43-53-68-75-79-83-92-95-127-130-143,toxin 1 producing STAPHYLOCOCCUS aureus and the presence of antibodies in menstruating women.,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352612,5/21/2015 12:56:30,1640297952,5/21/2015 12:55:47,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,Prevalence of TOXIC SHOCK SYNDROME toxin 1 producing,0-11-14-20-26-35-41-43,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724352613,5/21/2015 07:50:18,1640149941,5/21/2015 07:48:55,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 07:56:24,1640153527,5/21/2015 07:56:09,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 08:03:06,1640156942,5/21/2015 08:02:45,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 08:13:15,1640162397,5/21/2015 08:13:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 08:30:50,1640172046,5/21/2015 08:30:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 08:34:09,1640173886,5/21/2015 08:33:52,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 09:17:56,1640196215,5/21/2015 09:17:43,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 09:22:35,1640198365,5/21/2015 09:22:25,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 09:27:25,1640200847,5/21/2015 09:27:13,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352613,5/21/2015 09:28:26,1640201338,5/21/2015 09:28:08,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724352614,5/21/2015 07:47:38,1640148620,5/21/2015 07:45:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48,INSULIN,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 07:55:27,1640153044,5/21/2015 07:54:56,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 08:02:08,1640156348,5/21/2015 08:01:43,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,34-48,", INSULIN","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 08:12:25,1640161926,5/21/2015 08:12:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 08:29:52,1640171539,5/21/2015 08:29:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 08:33:11,1640173417,5/21/2015 08:32:39,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 09:17:05,1640195862,5/21/2015 09:16:17,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48,INSULIN,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 09:21:53,1640197992,5/21/2015 09:21:04,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,66,48,,,74,55,DIABETES,INSULIN,DIABETES mellitus,66-75,48-56,INSULIN dependent,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 09:26:24,1640200307,5/21/2015 09:26:06,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,66,48,,,74,55,DIABETES,INSULIN,DIABETES,66,48,INSULIN,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352614,5/21/2015 09:27:21,1640200805,5/21/2015 09:26:54,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,66,48,,,74,55,DIABETES,INSULIN,DIABETES mellitus,66-75,34-48-66-75,", INSULIN diabetes mellitus","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724352615,5/21/2015 12:51:36,1640295890,5/21/2015 12:51:19,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,6,116,,,15,121,POISONING,ERGOT,ergot POISONING An active principle isolated from ergot.,0-6-82-85-92-102-111-116,0-92-102-111-116-6,ergot poisoning principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 13:19:21,1640308294,5/21/2015 13:18:55,false,instagc,1.0,15285653,USA,"","",172.162.76.35,6,116,,,15,121,POISONING,ERGOT,ergot POISONING SEE: under poisoning ergotrate audio An active principle isolated from ergot.,0-6-19-24-32-45-73-82-85-92-102-111-116,0-6-24-32-45-82-92-102-111-116-85,ergot poisoning under poisoning ergotrate An active principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 13:30:53,1640314046,5/21/2015 13:30:14,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116-6,poisoning ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 13:36:21,1640316722,5/21/2015 13:35:08,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,6,116,,,15,121,POISONING,ERGOT,POISONING SEE: under poisoning,6-19-24-32,92-102-111-116,principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 13:55:09,1640326429,5/21/2015 13:54:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,6,116,,,15,121,POISONING,ERGOT,POISONING,6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 14:25:47,1640345611,5/21/2015 14:25:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 14:27:27,1640346565,5/21/2015 14:27:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,6,116,,,15,121,POISONING,ERGOT,ergot POISONING SEE: under poisoning ergotrate,0-6-19-24-32-45,92-102-111-116-85,active principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 14:28:40,1640347298,5/21/2015 14:28:30,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 14:29:21,1640347918,5/21/2015 14:28:59,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,6,116,,,15,121,POISONING,ERGOT,ergot POISONING SEE: under poisoning ergotrate,0-6-19-24-32-45,82-92-102-111-116-85,An active principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352615,5/21/2015 15:02:32,1640366862,5/21/2015 15:02:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724352616,5/21/2015 12:44:40,1640293055,5/21/2015 12:44:19,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia TACHYCARDIA,0-11-88-28,0-11-28-60-71-88,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA paroxysmal supraventricular tachycardia,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 12:50:19,1640295422,5/21/2015 12:50:06,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia shows paroxysmal supraventricular TACHYCARDIA from AV nodal,0-11-54-60-71-88-100-105-108-28,0-11-28-40-42-45-50-54-60-71-88,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead ECG shows paroxysmal supraventricular tachycardia,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 13:16:10,1640306660,5/21/2015 13:15:19,false,instagc,1.0,15285653,USA,"","",172.162.76.35,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12 lead ECG shows paroxysmal supraventricular TACHYCARDIA from AV nodal reentry (AVNRT.,0-11-28-40-42-45-50-54-60-71-88-100-105-108-114-122,0-11-28-40-42-45-50-54-60-71-88-100-105-108-114-122,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 13:29:06,1640313221,5/21/2015 13:28:17,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,A 12 lead paroxysmal supraventricular TACHYCARDIA,40-42-60-71-88-45,0-11-28-40-42-45,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 13:34:19,1640315856,5/21/2015 13:34:03,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 13:54:08,1640325780,5/21/2015 13:53:51,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,supraventricular TACHYCARDIA,71-88,0-11-28-40,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 14:24:09,1640344503,5/21/2015 14:22:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 14:25:28,1640345464,5/21/2015 14:25:18,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 14:25:35,1640345518,5/21/2015 14:25:01,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Tachycardia A 12 - lead ECG paroxysmal supraventricular TACHYCARDIA from AV nodal reentry (AVNRT.,28-40-42-44-45-50-60-71-88-100-105-108-114-122,0-11-28-40-42-45,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352616,5/21/2015 14:27:32,1640346592,5/21/2015 14:27:11,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724352617,5/21/2015 13:59:02,1640328800,5/21/2015 13:58:41,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 14:33:41,1640350516,5/21/2015 14:33:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 14:35:56,1640352017,5/21/2015 14:35:36,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,"podophyllin, podophyllotoxin, and imiquimod during PREGNANCY.",27-44-48-58-65-14,0-2-8-14-27-44-48,"• Avoid using PODOPHYLLIN, podophyllotoxin, and imiquimod","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 14:48:32,1640359472,5/21/2015 14:48:18,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,"Avoid using podophyllin, podophyllotoxin, and imiquimod during PREGNANCY.",2-8-14-44-48-58-65-27,0-2-8-14-27-44-48-58-65,"• Avoid using PODOPHYLLIN, podophyllotoxin, and imiquimod during pregnancy.","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 15:16:38,1640375190,5/21/2015 15:16:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 15:57:43,1640399390,5/21/2015 15:57:27,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14-65,"PODOPHYLLIN, pregnancy.","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 16:12:40,1640408388,5/21/2015 16:12:21,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 16:16:13,1640410845,5/21/2015 16:15:58,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 16:29:26,1640419654,5/21/2015 16:27:52,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14-27,"PODOPHYLLIN, podophyllotoxin,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352617,5/21/2015 16:40:21,1640426752,5/21/2015 16:38:51,false,points4rewards,1.0,28703583,USA,"","",97.73.83.199,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724352618,5/21/2015 13:34:44,1640316103,5/21/2015 13:34:01,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Advanced Pulmonary and Extrapulmonary TUBERCULOSIS,3-12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 13:40:23,1640318753,5/21/2015 13:39:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,123-130-137-151-162-165-174,"agents (e.g., streptomycin, ISONIAZID) to suppress manifestations","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 13:57:20,1640327840,5/21/2015 13:57:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 14:29:56,1640348337,5/21/2015 14:29:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 14:31:08,1640349040,5/21/2015 14:30:51,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Advanced Pulmonary and Extrapulmonary TUBERCULOSIS,3-12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 14:33:35,1640350388,5/21/2015 14:32:55,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS Systemically as adjunctive therapy with effective antimycobacterial,12-22-26-41-55-68-71-82-90-95-105,123-130-137-151-162-165-174-105,"antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 14:47:10,1640358807,5/21/2015 14:46:53,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS Systemically as adjunctive therapy,12-22-26-41-55-68-71-82,123-130-137-151-162-165-174-105,"antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 15:11:27,1640372179,5/21/2015 15:10:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Advanced Pulmonary and Extrapulmonary TUBERCULOSIS,3-12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 15:32:51,1640383617,5/21/2015 15:32:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352618,5/21/2015 15:48:42,1640393313,5/21/2015 15:48:26,false,instagc,1.0,23032978,USA,PA,Philadelphia,76.98.187.59,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724352619,5/21/2015 09:28:13,1640201199,5/21/2015 09:27:59,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 09:33:02,1640203743,5/21/2015 09:32:44,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 09:58:17,1640216094,5/21/2015 09:58:04,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:24:45,1640229064,5/21/2015 10:24:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:36:08,1640234299,5/21/2015 10:35:53,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY or planning pregnancy;,343-353-356-365,192-209-212,contraindication to WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:37:34,1640235155,5/21/2015 10:37:14,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:49:25,1640241476,5/21/2015 10:49:02,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:52:03,1640242862,5/21/2015 10:51:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 10:56:29,1640245029,5/21/2015 10:55:42,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,343,212,,,352,220,PREGNANCY,WARFARIN,anticardiolipin antibodies [INR] ≥ 2.0); PREGNANCY,28-44-329-335-337-343,24-28-117-129-212-140,"IgM anticardiolipin hemorrhage, stroke, gastrointestinal WARFARIN;","Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352619,5/21/2015 11:08:21,1640250383,5/21/2015 11:07:16,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,192-209-212,contraindication to WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724352620,5/21/2015 07:17:24,1640132609,5/21/2015 07:17:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"If negative iron balance persists, then IRON DEFICIENCY ANEMIA is the result.",0-3-17-25-35-40-45-56-63-66-70-12,0-3-12-17-25-35-40-45-56-63-66-70,"If negative IRON balance persists, then iron deficiency anemia is the result.","If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 07:21:28,1640134845,5/21/2015 07:21:13,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12-17,IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 07:29:38,1640139141,5/21/2015 07:29:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 07:47:13,1640148480,5/21/2015 07:46:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 07:54:12,1640152344,5/21/2015 07:53:49,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12-17,IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 07:57:03,1640153829,5/21/2015 07:56:40,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"negative iron balance persists, then IRON DEFICIENCY ANEMIA is the result.",3-17-25-35-40-45-56-63-66-70-12,0-3-12-17-25-35-56,"If negative IRON balance persists, then anemia","If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 08:01:08,1640155848,5/21/2015 08:00:49,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12-17,IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 08:06:03,1640158492,5/21/2015 08:05:46,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 08:22:14,1640167369,5/21/2015 08:21:44,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352620,5/21/2015 08:25:29,1640169142,5/21/2015 08:25:17,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12,IRON,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724352621,5/21/2015 14:35:18,1640351661,5/21/2015 14:34:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 14:37:50,1640353293,5/21/2015 14:37:12,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,198,132,,,200,139,MI,ASPIRIN,"carotid endarterectomy perioperative stroke, myocardial infarction (MI), and death after",65-153-167-175-186-197-203-207-213-57,57-65-119-122-127-132-140-144-153-167-175-186-197-219,"carotid endarterectomy as high dose ASPIRIN for reducing perioperative stroke, myocardial infarction (MI), CE.","PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 14:49:38,1640359994,5/21/2015 14:49:07,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI), and death after CE.",175-186-197-203-207-213-219,109-119-122-127-132-140-144-153-167-175-186-197-203-207-213-219,"effective as high dose ASPIRIN for reducing perioperative stroke, myocardial infarction (MI), and death after CE.","PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 15:20:04,1640376990,5/21/2015 15:19:27,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 15:59:50,1640400844,5/21/2015 15:59:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,198,132,,,200,139,MI,ASPIRIN,carotid endarterectomy,57-65,132-153,ASPIRIN perioperative,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 16:14:40,1640409759,5/21/2015 16:14:22,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 16:17:13,1640411383,5/21/2015 16:16:56,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 16:32:20,1640421768,5/21/2015 16:31:46,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 16:47:46,1640431777,5/21/2015 16:47:23,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352621,5/21/2015 16:48:00,1640431897,5/21/2015 16:46:54,false,vivatic,1.0,32338429,GBR,G1,Feltham,92.24.40.208,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132-140-144-153-167-175-186-197-203-207-213-219,"ASPIRIN for reducing perioperative stroke, myocardial infarction (MI), and death after CE.","PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724352622,5/21/2015 11:42:12,1640265142,5/21/2015 11:41:59,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,105,70,,,110,72,FEVER,PC,FEVER,105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 11:54:43,1640270976,5/21/2015 11:54:18,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,105,70,,,110,72,FEVER,PC,Unexplained in hospital FEVER following cardiac surgery.,81-93-96-105-111-121-129,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 12:40:27,1640291257,5/21/2015 12:40:05,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,105,70,,,110,72,FEVER,PC,FEVER cardiac surgery.,105-121-129,70-96-105,"PC, hospital fever","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 12:45:49,1640293608,5/21/2015 12:45:35,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,105,70,,,110,72,FEVER,PC,Unexplained in hospital FEVER following cardiac surgery.,81-93-96-105-111-121-129,54-61-64-70-74-77-81-93-96-105-111-121-129,"Newell J, Block PC, et al. Unexplained in hospital fever following cardiac surgery.","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 13:01:20,1640299898,5/21/2015 13:00:43,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,105,70,,,110,72,FEVER,PC,in hospital FEVER,93-96-105,43-51-54-61-64-70-74-77,"Sherman E, Newell J, Block PC, et al.","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 13:06:58,1640302254,5/21/2015 13:05:42,false,instagc,1.0,15285653,USA,"","",172.162.76.35,105,70,,,110,72,FEVER,PC,Unexplained in hospital FEVER following cardiac surgery.,81-93-96-105-111-121-129,54-61-64-70-74-77-81-93-96-105-111-121-129,"Newell J, Block PC, et al. Unexplained in hospital fever following cardiac surgery.","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 13:23:40,1640310400,5/21/2015 13:22:51,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,105,70,,,110,72,FEVER,PC,FEVER,105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 13:28:51,1640313051,5/21/2015 13:28:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,105,70,,,110,72,FEVER,PC,Unexplained in hospital FEVER,81-93-96-105,54-61-64-70,"Newell J, Block PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 13:49:58,1640323726,5/21/2015 13:49:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,105,70,,,110,72,FEVER,PC,FEVER,105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352622,5/21/2015 14:04:59,1640332464,5/21/2015 14:04:17,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,105,70,,,110,72,FEVER,PC,FEVER,105,70-105,"PC, fever","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724352623,5/21/2015 10:02:12,1640218177,5/21/2015 10:01:55,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 10:28:35,1640230762,5/21/2015 10:28:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 10:41:43,1640237258,5/21/2015 10:41:25,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 10:52:19,1640242938,5/21/2015 10:52:05,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 10:59:25,1640246482,5/21/2015 10:58:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 11:36:00,1640262226,5/21/2015 11:34:46,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,Treatment of HAIRY CELL LEUKEMIA,36-46-49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 11:39:35,1640264006,5/21/2015 11:39:18,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 12:35:25,1640288916,5/21/2015 12:34:48,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA interferon,49-55-60-138,49-55-138-60,hairy cell leukemia INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 12:42:22,1640292176,5/21/2015 12:41:58,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,Treatment of HAIRY CELL LEUKEMIA with granulocyte colony,36-46-49-55-60-69-74-86,36-46-49-55-112-116-128-138-149-152-164-60,Treatment of hairy cell leukemia and recombinant consensus INTERFERON or recombinant interferon,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352623,5/21/2015 12:55:11,1640297391,5/21/2015 12:54:37,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,Treatment of HAIRY CELL LEUKEMIA with granulocyte colony,36-46-49-55-60-69-74-86,93-112-116-128-138-149-152-164-105,stimulating factor and recombinant consensus INTERFERON or recombinant interferon,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724352624,5/21/2015 13:33:59,1640315651,5/21/2015 13:33:39,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 13:39:53,1640318506,5/21/2015 13:39:27,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM caused by production of botulinum toxin,0-9-16-19-30-33-43,33-43-49-52-56,BOTULINUM TOXIN in the colon,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 13:57:01,1640327650,5/21/2015 13:56:48,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 14:29:35,1640348060,5/21/2015 14:29:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 14:30:49,1640348836,5/21/2015 14:30:39,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 14:32:52,1640349955,5/21/2015 14:32:21,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM caused by production botulinum toxin colon ingestion spores Clostridium botulinum.,0-9-16-19-33-43-56-72-85-96-108,16-19-30-33-43-49-52-56-96-108,by production of BOTULINUM TOXIN in the colon Clostridium botulinum.,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 14:46:52,1640358570,5/21/2015 14:46:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM caused by production of botulinum toxin in the colon,0-9-16-19-30-33-43-49-52-56,0-16-19-30-33-43-49-52-56-9,Botulism caused by production of BOTULINUM TOXIN in the colon,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 15:10:30,1640371552,5/21/2015 15:09:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 15:22:37,1640378363,5/21/2015 15:22:32,false,neodev,1.0,32491845,USA,"","",208.31.49.58,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM caused by production,0-9-16-19,16-19-30-33-43-49-52-56,by production of BOTULINUM TOXIN in the colon,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352624,5/21/2015 15:32:32,1640383451,5/21/2015 15:32:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724352625,5/21/2015 07:40:59,1640145202,5/21/2015 07:39:44,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 07:52:52,1640151487,5/21/2015 07:52:26,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58,SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 08:00:07,1640155395,5/21/2015 07:59:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 08:01:27,1640156044,5/21/2015 08:01:13,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,"Ketoconazole shampoo the treatment of TINEA VERSICOLOR: a multicenter, randomized,",58-69-73-83-86-92-104-106-119-42,38-42-55-58-66-69-73-86-92,al. Ketoconazole 2% SHAMPOO in the treatment tinea versicolor:,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 08:10:34,1640160873,5/21/2015 08:10:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58-66-69-73-83-86-92,SHAMPOO in the treatment of tinea versicolor:,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 08:27:44,1640170315,5/21/2015 08:27:15,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 08:30:42,1640171973,5/21/2015 08:30:09,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 09:14:40,1640194693,5/21/2015 09:14:22,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58,SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 09:19:29,1640196933,5/21/2015 09:19:12,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352625,5/21/2015 09:25:00,1640199557,5/21/2015 09:23:02,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58,SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724352626,5/21/2015 07:43:26,1640146304,5/21/2015 07:43:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81-95,1 mg DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 07:53:37,1640152010,5/21/2015 07:53:17,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81-95,DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 08:00:59,1640155807,5/21/2015 08:00:34,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81-95,1 mg DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 08:02:17,1640156393,5/21/2015 08:02:09,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,evaluating women for CUSHING'S SYNDROME vs. polycystic ovary dexamethasone discriminatory,5-16-22-26-36-45-49-60-153-81,36-66-76-78-81-95-107-110-26,"Cushing's syndrome syndrome, 1 mg DEXAMETHASONE suppression or midnight","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 08:11:29,1640161448,5/21/2015 08:11:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81-95,DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 08:28:30,1640170706,5/21/2015 08:28:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81,DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 08:31:49,1640172524,5/21/2015 08:31:26,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81,1 mg DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 09:15:23,1640195052,5/21/2015 09:15:01,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81,DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 09:20:15,1640197299,5/21/2015 09:19:56,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81-95,1 mg DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352626,5/21/2015 09:26:02,1640200150,5/21/2015 09:25:02,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,"CUSHING'S SYNDROME polycystic ovary syndrome,",26-36-49-60-66,26-36-60-66-81,"Cushing's syndrome ovary syndrome, DEXAMETHASONE","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724352627,5/21/2015 07:24:15,1640136405,5/21/2015 07:23:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",0-17-36-47-54-61-69-75-80-90-98-107-114-124-132-145-162-166-174-179-182-196-201,0-17-36-47-54-61-69-75-80-90-98-107-114-124-132-145-162-166-174-179-182-196-201,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS, and argyria must be distinguished from EDP.","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 07:38:41,1640143900,5/21/2015 07:38:10,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 07:52:14,1640151155,5/21/2015 07:51:52,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 07:59:27,1640155060,5/21/2015 07:59:03,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 08:00:50,1640155718,5/21/2015 08:00:34,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION, pityriasis rosea, lichen amyloidosis, hemochromatosis, argyria",0-17-36-47-54-132-145-166,114-124-132-145-162-166-174-201-98,"disease, syphilis, macular amyloidosis, HEMOCHROMATOSIS, and argyria must EDP.","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 08:09:52,1640160543,5/21/2015 08:09:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 08:26:56,1640169972,5/21/2015 08:26:35,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"HYPERPIGMENTATION,",17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 08:29:49,1640171503,5/21/2015 08:29:21,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 09:14:08,1640194412,5/21/2015 09:13:48,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352627,5/21/2015 09:18:58,1640196691,5/21/2015 09:18:17,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"HYPERPIGMENTATION,",17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724352628,5/21/2015 11:41:44,1640264909,5/21/2015 11:41:33,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 11:51:20,1640269359,5/21/2015 11:50:52,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,"poten<span id=""transmark""></span>tially life threatening ASCITES",191-196-208-179,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 12:39:36,1640290960,5/21/2015 12:39:17,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,Ovarian hyperstimulation syndrome ASCITES,0-8-208-25,0-8-25-208,OVARIAN HYPERSTIMULATION SYNDROME ascites,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 12:45:20,1640293433,5/21/2015 12:45:03,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,Ovarian hyperstimulation syndrome causing potentially life threatening ASCITES and hypovolemia.,0-8-25-179-191-196-208-216-220-171,0-8-25-34-41-44-47-50-57-54,OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients;,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:00:14,1640299422,5/21/2015 12:59:34,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,"intravascular fluid volume shifts into the peritoneal space, ASCITES",110-124-130-137-144-149-153-164-208,0-8-25-67-75-79-86-96,"OVARIAN HYPERSTIMULATION SYNDROME ovaries can become massively enlarged,","Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:05:15,1640301547,5/21/2015 13:03:54,false,instagc,1.0,15285653,USA,"","",172.162.76.35,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",0-8-25-34-41-44-47-50-54-57-67-79-86-96-106-110-124-130-137-144-149-153-164-179-191-196-208-216-220-171,0-8-25-34-41-44-47-50-54-57-67-75-79-86-96-106-110-124-130-137-144-149-153-164-171-179-191-196-208-216-220,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ascites and hypovolemia.","Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:22:16,1640309663,5/21/2015 13:21:56,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:28:13,1640312641,5/21/2015 13:27:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,potentially life threatening ASCITES,179-191-196-208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:43:44,1640320391,5/21/2015 13:43:16,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352628,5/21/2015 13:46:20,1640321754,5/21/2015 13:46:02,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,potentially life threatening ASCITES hypovolemia.,179-191-196-208-220,0-8-25-34-44,OVARIAN HYPERSTIMULATION SYNDROME occurs 10,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724352629,5/21/2015 10:03:39,1640218850,5/21/2015 10:03:09,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 10:29:55,1640231389,5/21/2015 10:29:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 10:42:38,1640237792,5/21/2015 10:42:24,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 10:53:03,1640243347,5/21/2015 10:52:50,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 11:02:50,1640248013,5/21/2015 11:02:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 11:40:18,1640264347,5/21/2015 11:40:04,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 11:46:41,1640267369,5/21/2015 11:46:06,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,19-27-33-36-42-45-56-59-70-79-82-92-100-103-107-113-122-126,"finding toxin in serum or isolating C. BOTULINUM organism on anaerobic culture of the wound confirms the dia<span id=""transmark""></span>gnosis.","In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 12:37:14,1640289730,5/21/2015 12:36:54,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM, botulinum organism",3-9-59-70,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 12:43:30,1640292613,5/21/2015 12:43:05,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"In WOUND BOTULISM, finding toxin isolating C. botulinum organism",0-3-9-19-27-45-56-59-70,9-36-42-45-56-59-70-79-82-113-122-126,"botulism, serum or isolating C. BOTULINUM organism on anaerobic confirms the diagnosis.","In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352629,5/21/2015 12:57:07,1640298246,5/21/2015 12:56:31,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"In WOUND BOTULISM, finding toxin in serum",0-3-9-19-27-33-36,27-36-42-45-56-59-70-79-82-33,toxin in serum or isolating C. BOTULINUM organism on anaerobic,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724352630,5/21/2015 13:35:18,1640316365,5/21/2015 13:34:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 13:41:01,1640318978,5/21/2015 13:40:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA,",39-56-66-74,0-7-16-19-23-27,Common features of TTP and HUS,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 13:57:38,1640328070,5/21/2015 13:57:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 14:30:35,1640348696,5/21/2015 14:29:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 14:31:20,1640349179,5/21/2015 14:31:09,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 14:33:58,1640350758,5/21/2015 14:33:36,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"TTP HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA, and the presence",19-27-39-56-66-74-92-96-100-31,0-7-16-19-23-27-31-39-56-66-74-112-121-128,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, platelet fibrin thrombi","Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 14:47:24,1640358988,5/21/2015 14:47:11,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA, and the presence of platelet fibrin thrombi",39-56-66-74-92-96-100-109-112-121-128,0-7-16-19-23-27-31-39-56-66-74,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia,","Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 15:12:26,1640372738,5/21/2015 15:11:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 15:33:07,1640383685,5/21/2015 15:32:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352630,5/21/2015 15:48:56,1640393465,5/21/2015 15:48:43,false,instagc,1.0,23032978,USA,PA,Philadelphia,76.98.187.59,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724352631,5/21/2015 13:23:58,1640310530,5/21/2015 13:22:59,false,instagc,1.0,15285653,USA,"","",172.162.76.35,190,141,,,197,156,MALARIA,QUININE SULFATE,At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of P. falciparum MALARIA.,6-9-15-17-22-25-31-43-54-63-66-68-78-86-91-103-113-116-125-129-138-141-149-157-171-175-178-190-161,6-9-15-17-22-25-31-43-54-63-66-68-78-86-91-103-113-116-125-129-138-141-149-157-161-171-175-178-190,At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV QUININE SULFATE for treatment of P. falciparum malaria.,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 13:33:11,1640315148,5/21/2015 13:32:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,141-149,QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 13:39:04,1640318070,5/21/2015 13:38:44,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,190,141,,,197,156,MALARIA,QUININE SULFATE,falciparum MALARIA.,178-190,141-149-157-161-171-175-178-190,QUININE SULFATE for treatment of P. falciparum malaria.,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 13:56:32,1640327348,5/21/2015 13:56:20,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,190,141,,,197,156,MALARIA,QUININE SULFATE,MALARIA.,190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 14:28:41,1640347333,5/21/2015 14:28:25,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,141-149,QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 14:30:11,1640348462,5/21/2015 14:30:01,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 14:31:51,1640349424,5/21/2015 14:31:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,190,141,,,197,156,MALARIA,QUININE SULFATE,ventricular arrhythmia preexisting prolonged QT interval IV quinine sulfate treatment of P. falciparum MALARIA.,31-43-91-103-113-116-138-141-149-171-175-178-190-161,138-141-149-190-178,IV QUININE SULFATE falciparum malaria.,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 14:46:19,1640358138,5/21/2015 14:46:00,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,190,141,,,197,156,MALARIA,QUININE SULFATE,who received IV quinine sulfate for treatment of P. falciparum MALARIA.,125-129-138-141-149-157-171-175-178-190-161,125-129-138-141-149-157-161-171-175-178-190,who received IV QUININE SULFATE for treatment of P. falciparum malaria.,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 15:05:09,1640368353,5/21/2015 15:04:57,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352631,5/21/2015 15:08:12,1640370277,5/21/2015 15:06:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724352632,5/21/2015 09:27:42,1640200972,5/21/2015 09:27:23,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 09:32:28,1640203495,5/21/2015 09:32:10,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,53,126,,,55,138,P.,TRIMETHOPRIM,P.,53,126,TRIMETHOPRIM,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 09:57:35,1640215707,5/21/2015 09:57:06,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-147,TRIMETHOPRIM thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:24:13,1640228868,5/21/2015 10:23:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii )",18-31-41-53-56-64,109-121-126,prophylaxis with TRIMETHOPRIM,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:35:39,1640234120,5/21/2015 10:35:25,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii",18-31-41-53-56,101-109-121-126-139-147,routine prophylaxis with TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:36:46,1640234729,5/21/2015 10:36:22,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:48:45,1640241056,5/21/2015 10:48:02,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:50:23,1640242038,5/21/2015 10:49:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 10:54:42,1640244200,5/21/2015 10:54:07,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii has essentially trimethoprim sulfame thoxazole",18-31-41-53-56-66-70-126-139-147,18-101-109-121-126-139-147-157-31,Pneumocystis jiroveci routine prophylaxis with TRIMETHOPRIM sulfame thoxazole or,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352632,5/21/2015 11:05:54,1640249303,5/21/2015 11:04:38,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii",18-31-41-53-56,109-121-126-139-147,prophylaxis with TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724352633,5/21/2015 07:21:52,1640135107,5/21/2015 07:21:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,32,57,,,34,60,TB,PPD,Patients should be screened for TB with a chest x ray or PPD.,0-9-16-19-28-32-35-40-42-48-50-54-57,0-9-16-19-28-32-35-40-48-50-54-57-42,Patients should be screened for TB with a chest x ray or PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 07:35:25,1640142253,5/21/2015 07:34:42,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 07:50:31,1640150093,5/21/2015 07:50:13,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 07:57:54,1640154191,5/21/2015 07:57:34,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 07:59:51,1640155300,5/21/2015 07:59:34,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,32,57,,,34,60,TB,PPD,Patients be screened for TB with a chest,16-19-28-32-35-40-42-0,48-50-54-57-32,TB x ray or PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 08:08:38,1640159954,5/21/2015 08:08:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,32,57,,,34,60,TB,PPD,TB,32,48-50-54-57,x ray or PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 08:25:28,1640169140,5/21/2015 08:25:10,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 08:27:52,1640170425,5/21/2015 08:27:33,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 09:06:50,1640190422,5/21/2015 09:06:38,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352633,5/21/2015 09:12:29,1640193542,5/21/2015 09:12:14,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724352634,5/21/2015 07:48:54,1640149240,5/21/2015 07:48:27,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 07:56:08,1640153395,5/21/2015 07:55:42,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 08:02:44,1640156682,5/21/2015 08:02:26,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 08:13:00,1640162289,5/21/2015 08:12:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,128-137-142,patients with FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 08:30:28,1640171863,5/21/2015 08:30:10,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 08:33:51,1640173788,5/21/2015 08:33:34,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 09:17:41,1640196133,5/21/2015 09:17:24,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 09:22:24,1640198243,5/21/2015 09:22:10,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 09:27:12,1640200730,5/21/2015 09:26:41,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352634,5/21/2015 09:28:07,1640201170,5/21/2015 09:27:48,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,98,142,,,104,145,ATAXIA,FFI,"ATAXIA, dementia;",98-118,118-142,dementia; FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724352635,5/21/2015 07:44:58,1640147242,5/21/2015 07:43:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 07:54:33,1640152493,5/21/2015 07:53:38,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 08:01:19,1640155960,5/21/2015 08:01:00,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,uncomplicated GONORRHOEA,61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 08:11:49,1640161613,5/21/2015 08:11:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 08:28:56,1640170960,5/21/2015 08:28:31,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 08:32:11,1640172796,5/21/2015 08:31:50,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 09:15:42,1640195147,5/21/2015 09:15:24,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 09:20:43,1640197493,5/21/2015 09:20:17,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 09:25:39,1640199893,5/21/2015 09:25:23,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,94-103-108,patients with CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352635,5/21/2015 09:26:27,1640200320,5/21/2015 09:26:05,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724352636,5/21/2015 13:21:56,1640309539,5/21/2015 13:21:20,false,instagc,1.0,15285653,USA,"","",172.162.76.35,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,"The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES.",20-24-34-42-46-51-65-68-76-83-88-91-102-115-123-140-143-152-157-162-164-132,20-24-34-42-46-51-65-68-76-83-88-91-102-115-123-132-140-143-152-157-162-164,"The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.","Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 13:32:11,1640314769,5/21/2015 13:31:46,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 13:37:33,1640317353,5/21/2015 13:37:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,patients with TYPE 1 DIABETES.,143-152-157-162-164,46-51-65-68-76,pump compatibility of INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 13:55:58,1640327039,5/21/2015 13:55:44,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 14:28:00,1640346979,5/21/2015 14:27:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 14:29:32,1640348022,5/21/2015 14:29:20,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 14:30:22,1640348521,5/21/2015 14:29:31,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,46-68-76-51,pump compatibility INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 14:45:45,1640357909,5/21/2015 14:45:31,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,insulin infusion therapy in patients with TYPE 1 DIABETES.,115-123-140-143-152-157-162-164-132,46-51-65-68-76-83-88-91-102-115-123-132,pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 15:04:43,1640368140,5/21/2015 15:04:31,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352636,5/21/2015 15:06:28,1640369252,5/21/2015 15:04:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724352637,5/21/2015 12:43:52,1640292769,5/21/2015 12:43:34,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-160-149,144-160,IRON anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 12:49:45,1640295148,5/21/2015 12:49:18,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,160,144,,,166,148,ANEMIA,IRON,"iron deficiency in the absence of anemia, than iron deficiency ANEMIA vs 1.6%)",58-63-74-77-81-89-139-144-149-160-173-176-92,58-63-74-77-81-92-124-129-139-144-149-160-89,"iron deficiency in the absence of anemia, more prevalent than IRON deficiency anemia","Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 13:14:36,1640305591,5/21/2015 13:13:27,false,instagc,1.0,15285653,USA,"","",172.162.76.35,160,144,,,166,148,ANEMIA,IRON,"advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency ANEMIA (6.4% vs 1.6%) (2, 3.",31-41-55-58-63-74-77-81-89-92-100-102-112-117-120-124-129-139-144-149-160-167-173-176-183-187,41-55-58-63-74-77-81-89-92-100-102-112-117-120-124-129-139-144-149-160-167-173-176-183-187,"investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than IRON deficiency anemia (6.4% vs 1.6%) (2, 3.","Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 13:27:53,1640312481,5/21/2015 13:27:33,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 13:33:10,1640315140,5/21/2015 13:32:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,160,144,,,166,148,ANEMIA,IRON,than iron deficiency ANEMIA,139-144-149-160,124-129-139-144-149,more prevalent than IRON deficiency,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 13:53:29,1640325400,5/21/2015 13:53:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 14:22:17,1640343319,5/21/2015 14:22:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 14:23:48,1640344225,5/21/2015 14:23:19,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,160,144,,,166,148,ANEMIA,IRON,"than iron deficiency ANEMIA (6.4% vs 1.6%) (2, 3.",139-144-149-160-167-173-176-187-183,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 14:25:03,1640345183,5/21/2015 14:24:49,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,160,144,,,166,148,ANEMIA,IRON,ANEMIA,160,144-149,IRON deficiency,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352637,5/21/2015 14:26:53,1640346346,5/21/2015 14:26:38,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724352638,5/21/2015 11:42:26,1640265273,5/21/2015 11:42:14,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,149,"ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 12:12:35,1640278708,5/21/2015 12:12:08,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG, caused by inhalation of hay du<span id=""transmark""></span>st",77-86-92-99-102-113-116-120,116-120-125-136-149,"hay dust containing thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 12:40:49,1640291425,5/21/2015 12:40:29,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG, inhalation of hay dust",77-86-102-113-116-120,149-136,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 12:46:16,1640293757,5/21/2015 12:45:50,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"55 4 ); FARMER'S LUNG, caused by inhalation of hay dust containing thermophilic actinomycetes,",69-72-74-77-86-92-99-102-113-116-120-125-136-149,77-86-92-99-102-113-120-125-136-149-164-167-171-116,"farmer's lung, caused by inhalation of hay dust containing thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 13:01:46,1640300055,5/21/2015 13:01:21,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG, caused by inhalation of hay dust",77-86-92-99-102-113-116-120,120-125-136-149-164-167-171,"dust containing thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 13:07:24,1640302420,5/21/2015 13:06:59,false,instagc,1.0,15285653,USA,"","",172.162.76.35,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"55 4 ); FARMER'S LUNG, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",69-72-74-77-86-92-99-102-113-116-120-125-136-149-164-167-171,77-86-92-99-102-113-120-125-136-149-164-167-171-116,"farmer's lung, caused by inhalation of hay dust containing thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 13:24:08,1640310682,5/21/2015 13:23:41,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 13:29:25,1640313345,5/21/2015 13:28:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"); FARMER'S LUNG, caused by inhalation",74-77-86-92-99-102,136-149-164-167-171,"thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 13:50:22,1640323920,5/21/2015 13:49:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352638,5/21/2015 14:05:49,1640332941,5/21/2015 14:05:02,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724352639,5/21/2015 13:20:27,1640308827,5/21/2015 13:19:22,false,instagc,1.0,15285653,USA,"","",172.162.76.35,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,difficile associated diarrhea and colitis (CDAD; also known as antibiotic associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.,43-54-65-74-78-86-93-98-104-107-118-129-138-142-150-153-170-179-183-188-197-202-209-213-218-229-233-237-246-255-260-265-274-277-283-243,43-54-65-74-78-86-93-98-104-107-118-129-138-142-150-153-170-179-183-188-197-202-209-213-218-229-233-237-243-246-255-260-265-274-277-283,difficile associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild diarrhea to fatal colitis.,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 13:31:15,1640314217,5/21/2015 13:30:54,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 13:36:45,1640316893,5/21/2015 13:36:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,severity from mild DIARRHEA,246-255-260-265,107-118-129-138-142,ANTIBIOTIC ASSOCIATED DIARRHEA and colitis,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 13:55:27,1640326661,5/21/2015 13:55:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 14:27:18,1640346549,5/21/2015 14:25:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 14:28:40,1640347288,5/21/2015 14:27:36,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,severity from mild DIARRHEA,246-255-260-265,93-98-104-107-118-129-138-142-150-153-170-86,(CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis),"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 14:28:54,1640347489,5/21/2015 14:28:42,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,mild DIARRHEA,260-265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 14:29:51,1640348265,5/21/2015 14:29:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA to fatal colitis.,265-274-277-283,107-118-129-138-142-150-153-170,ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis),"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 15:04:09,1640367789,5/21/2015 15:02:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,mild DIARRHEA,260-265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352639,5/21/2015 15:04:18,1640367924,5/21/2015 15:03:52,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724352640,5/21/2015 09:33:46,1640204112,5/21/2015 09:33:34,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,117,GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 09:59:33,1640216829,5/21/2015 09:59:00,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:25:27,1640229378,5/21/2015 10:25:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE (donovanosis),53-63-73,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:36:57,1640234867,5/21/2015 10:36:49,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,Treatment of GRANULOMA INGUINALE,40-50-53-63,87-94-98-117,caused by Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:38:30,1640235568,5/21/2015 10:38:12,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:50:14,1640241943,5/21/2015 10:50:00,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:55:01,1640244364,5/21/2015 10:54:30,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE (donovanosis),53-63-73,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 10:58:46,1640246173,5/21/2015 10:58:03,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,(Donovanosis) GRANULOMA INGUINALE Calymmatobacterium granulomatis.,25-53-63-98-117,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 11:21:55,1640256089,5/21/2015 11:21:02,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,"Granuloma Inguinale (Donova<span id=""transmark""></span>nosis) Treatment of GRANULOMA INGUINALE",5-15-40-50-53-63-25,53-63-87-94-98-117-73,"granuloma inguinale (donova<span id=""transmark""></span>nosis) caused by Calymmatobacterium GRANULOMATIS.",102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352640,5/21/2015 11:37:40,1640263052,5/21/2015 11:37:28,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,117,GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724352641,5/21/2015 07:01:06,1640123794,5/21/2015 07:00:54,false,clixsense,1.0,6352682,GBR,H9,London,2.122.19.138,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,alosetron patients who develop ISCHEMIC COLITIS.,32-41-45-53-62-19,5-8-12-19-29-32-41,Do not resume ALOSETRON in patients who,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:12:40,1640129988,5/21/2015 07:12:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,Do not resume alosetron in patients who develop ISCHEMIC COLITIS.,5-8-12-19-32-41-45-53-62-29,5-8-12-19-29-32-41-45-53-62,Do not resume ALOSETRON in patients who develop ischemic colitis.,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:18:17,1640133092,5/21/2015 07:18:06,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:27:06,1640137863,5/21/2015 07:26:48,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:33:43,1640141359,5/21/2015 07:33:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:45:11,1640147384,5/21/2015 07:44:51,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:51:05,1640150405,5/21/2015 07:50:52,false,elite,1.0,31913360,GBR,"","",88.150.133.60,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,patients who develop ISCHEMIC COLITIS.,32-41-45-53-62,5-8-12-19-29-32-41,Do not resume ALOSETRON in patients who,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:51:58,1640151037,5/21/2015 07:51:14,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:54:39,1640152567,5/21/2015 07:53:39,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,resume alosetron patients who develop ISCHEMIC COLITIS.,19-32-41-45-53-62-12,5-8-12-19-29-32-41-45-53-62,Do not resume ALOSETRON in patients who develop ischemic colitis.,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352641,5/21/2015 07:59:00,1640154809,5/21/2015 07:58:37,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724352642,5/21/2015 13:21:19,1640309269,5/21/2015 13:20:28,false,instagc,1.0,15285653,USA,"","",172.162.76.35,131,91,,,141,101,INFARCTION,DALTEPARIN,"CONCLUSION In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial INFARCTION at 1 month but not at 3 months.",0-12-15-24-28-37-49-60-64-73-82-91-102-110-116-120-131-142-145-147-153-157-161-164-166,0-12-15-24-28-37-49-60-64-73-82-91-102-110-116-120-131-142-145-147-153-157-161-164-166,"CONCLUSION In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and myocardial infarction at 1 month but not at 3 months.","CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 13:31:45,1640314529,5/21/2015 13:31:15,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 13:37:17,1640317180,5/21/2015 13:36:46,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,131,91,,,141,101,INFARCTION,DALTEPARIN,death and myocardial INFARCTION,110-116-120-131,64-73-82-91,"unstable coronary disease, DALTEPARIN","CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 13:55:42,1640326855,5/21/2015 13:55:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,131-120,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 14:27:41,1640346740,5/21/2015 14:27:20,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 14:29:18,1640347860,5/21/2015 14:28:55,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 14:29:29,1640348007,5/21/2015 14:28:41,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION at,120-131-142,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 14:30:08,1640348435,5/21/2015 14:29:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,131,91,,,141,101,INFARCTION,DALTEPARIN,reduced death and myocardial INFARCTION at 1 month but not at 3 months.,102-110-116-120-131-142-145-147-153-157-161-164-166,64-73-82-91-102-110-116-120-131,"unstable coronary disease, DALTEPARIN reduced death and myocardial infarction","CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 15:04:31,1640368030,5/21/2015 15:04:19,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352642,5/21/2015 15:04:58,1640368246,5/21/2015 15:04:11,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724352643,5/21/2015 07:43:01,1640146172,5/21/2015 07:41:00,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,severe disseminated HISTOPLASMOSIS:,65-72-85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 07:53:15,1640151784,5/21/2015 07:52:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 08:00:33,1640155565,5/21/2015 08:00:09,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 08:02:08,1640156332,5/21/2015 08:01:29,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,to severe disseminated HISTOPLASMOSIS: Initial regimen of itraconazole,62-65-72-85-101-109-117-180,65-109-117-120-123-136-138-144-148-85,severe histoplasmosis: regimen of IV AMPHOTERICIN B given for at,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 08:11:11,1640161224,5/21/2015 08:10:36,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,109-117-120-123-136,regimen of IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 08:28:07,1640170548,5/21/2015 08:27:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 08:31:25,1640172359,5/21/2015 08:30:44,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 09:15:00,1640194861,5/21/2015 09:14:41,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 09:19:55,1640197159,5/21/2015 09:19:30,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352643,5/21/2015 09:25:21,1640199730,5/21/2015 09:25:01,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724352644,5/21/2015 11:43:05,1640265607,5/21/2015 11:42:53,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 12:14:44,1640279580,5/21/2015 12:14:24,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,screening for CUSHING'S SYNDROME.,63-73-77-87,4-14-28,overnight DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 12:41:46,1640291878,5/21/2015 12:41:29,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,dexamethasone test CUSHING'S SYNDROME.,14-77-87-28,14-77-87,DEXAMETHASONE Cushing's syndrome.,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 12:47:22,1640294143,5/21/2015 12:47:01,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,overnight dexamethasone test is the procedure of choice in screening for CUSHING'S SYNDROME.,14-28-33-36-40-50-53-60-63-73-77-87-4,0-4-14-28-33-36-40-50-53-60-63-73-77-87,The overnight DEXAMETHASONE test is the procedure of choice in screening for Cushing's syndrome.,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 13:08:59,1640303013,5/21/2015 13:08:33,false,instagc,1.0,15285653,USA,"","",172.162.76.35,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,procedure of choice in screening for CUSHING'S SYNDROME.,40-50-60-63-73-77-87-53,0-4-14-28-33-36-40-50-53-60-63-73-77-87,The overnight DEXAMETHASONE test is the procedure of choice in screening for Cushing's syndrome.,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 13:25:14,1640311145,5/21/2015 13:24:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14-28,DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 13:30:35,1640313886,5/21/2015 13:30:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,screening for CUSHING'S SYNDROME.,63-73-77-87,0-4-14-28,The overnight DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 13:51:44,1640324646,5/21/2015 13:51:19,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 14:07:22,1640334039,5/21/2015 14:07:03,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352644,5/21/2015 14:18:50,1640341242,5/21/2015 14:18:09,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724352645,5/21/2015 08:32:49,1640173197,5/21/2015 08:32:24,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:19:51,1640197128,5/21/2015 09:19:34,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:24:06,1640199048,5/21/2015 09:23:53,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:29:13,1640201831,5/21/2015 09:28:58,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,BLINDNESS,56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:30:08,1640202272,5/21/2015 09:29:51,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:50:49,1640212349,5/21/2015 09:50:37,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,BLINDNESS,56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 09:52:11,1640212965,5/21/2015 09:51:54,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 10:08:16,1640221089,5/21/2015 10:07:47,false,vivatic,1.0,13889585,GBR,A1,Dagenham,2.28.66.9,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 10:17:42,1640225757,5/21/2015 10:17:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352645,5/21/2015 10:20:58,1640227391,5/21/2015 10:19:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724352646,5/21/2015 14:34:17,1640351055,5/21/2015 14:34:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 14:37:10,1640352878,5/21/2015 14:36:56,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,Fructose 1 phosphate aldolase (aldolase B) deficiency: This DEFICIENCY causes the clinical,9-11-21-30-40-43-56-61-72-79-83-0,83-92-101-104-115-124,clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 14:49:06,1640359756,5/21/2015 14:48:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,(aldolase B) deficiency: This DEFICIENCY causes the clinical syndrome of hereditary fructose intolerance.,30-40-43-56-61-72-79-83-92-101-104-115-124,83-92-101-104-115-124,clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 15:19:25,1640376692,5/21/2015 15:18:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,phosphate aldolase DEFICIENCY,11-21-61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 15:59:18,1640400535,5/21/2015 15:58:15,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 16:14:21,1640409619,5/21/2015 16:13:22,false,instagc,1.0,30758231,USA,NY,Oneida,67.249.200.111,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 16:16:55,1640411223,5/21/2015 16:16:31,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,Fructose 1 - phosphate aldolase (aldolase B) DEFICIENCY,0-9-10-11-21-30-61-40,83-92-104-115-124-101,clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 16:31:43,1640421269,5/21/2015 16:31:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 16:43:22,1640428940,5/21/2015 16:42:10,false,points4rewards,1.0,28703583,USA,"","",97.73.83.199,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,Fructose 1 phosphate aldolase (aldolase B) deficiency: DEFICIENCY,0-9-11-21-40-43-61-30,0-9-11-21-30-40-43-104-115-124,Fructose 1 phosphate aldolase (aldolase B) deficiency: HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352646,5/21/2015 16:46:56,1640431459,5/21/2015 16:46:18,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724352647,5/21/2015 09:26:43,1640200469,5/21/2015 09:26:25,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 09:31:40,1640203083,5/21/2015 09:31:16,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53,BRUCELLA,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 09:32:26,1640203477,5/21/2015 09:32:11,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,Brucellosis Treatment of BRUCELLOSIS by,4-17-27-30-49,17-27-53-62-30,Treatment of brucellosis BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 09:56:28,1640215157,5/21/2015 09:56:06,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:21:42,1640227733,5/21/2015 10:21:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:34:59,1640233800,5/21/2015 10:34:44,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS caused by Brucella,30-42-49-53,30-42-49-53-62,brucellosis caused by BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:35:32,1640234060,5/21/2015 10:35:12,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:45:55,1640239594,5/21/2015 10:44:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:47:26,1640240381,5/21/2015 10:47:08,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352647,5/21/2015 10:49:25,1640241461,5/21/2015 10:49:12,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724352648,5/21/2015 10:43:31,1640238294,5/21/2015 10:43:18,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 10:53:40,1640243674,5/21/2015 10:53:32,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 11:41:03,1640264655,5/21/2015 11:40:49,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA,0,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 11:48:44,1640268275,5/21/2015 11:47:49,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35-48-53-59-66,"LEGIONELLA PNEUMOPHILA most often causes pn<span id=""transmark""></span>eumonia,","LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 12:38:34,1640290406,5/21/2015 12:38:10,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA pneumophila,0-35,24-35-12,INFECTIONS LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 12:44:24,1640292986,5/21/2015 12:44:12,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,"LEGIONELLA INFECTIONS Legionella pneumophila often causes pneumonia,",0-12-24-35-53-59-66,0-12-24-35-48-53-59-66,"LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes pneumonia,","LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 12:58:22,1640298755,5/21/2015 12:57:57,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS Legionella pneumophila,0-12-24-35,0-12-24-35-48-53-59-66,"LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes pneumonia,","LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 13:02:33,1640300335,5/21/2015 13:02:10,false,instagc,1.0,15285653,USA,"","",172.162.76.35,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,"LEGIONELLA INFECTIONS Legionella pneumophila most often causes pneumonia, with extrapulmonary features.",0-12-24-35-48-53-59-66-77-82-97,0-12-24-35-48-53-59-66-77-82-97,"LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes pneumonia, with extrapulmonary features.","LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 13:15:15,1640306116,5/21/2015 13:14:36,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA,0,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352648,5/21/2015 13:20:37,1640308936,5/21/2015 13:20:33,false,clixsense,1,30681680,NLD,11,Rotterdam,87.211.12.50,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS Legionella pneumophila,0-12-24-35,0-12-24-35-48-53-59,LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724352649,5/21/2015 11:42:52,1640265520,5/21/2015 11:42:39,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS,112,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 12:14:23,1640279433,5/21/2015 12:13:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin for chronic HEPATITIS C,90-100-104-112-122,40-52-62-78-83-86-90-100-104-112-67,"Combination treatment with interfe<span id=""transmark""></span>ron alfa 2b and RIBAVIRIN for chronic hepatitis","Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 12:41:27,1640291728,5/21/2015 12:41:06,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin HEPATITIS,112-90,90-104-112-122,RIBAVIRIN chronic hepatitis C,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 12:47:00,1640293987,5/21/2015 12:46:28,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,112,90,,,121,99,HEPATITIS,RIBAVIRIN,treatment with interferon alfa 2b ribavirin for chronic HEPATITIS C in patients who failed to achieve sustained response to interferon,52-62-67-78-83-90-100-104-112-122-124-127-136-145-152-155-163-173-182-185,78-83-86-90-100-104-112-122-124-127-136-140-145-152-155-173-185,alfa 2b and RIBAVIRIN for chronic hepatitis C in patients who have failed to achieve response interferon,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 13:08:32,1640302859,5/21/2015 13:07:43,false,instagc,1.0,15285653,USA,"","",172.162.76.35,112,90,,,121,99,HEPATITIS,RIBAVIRIN,Combination treatment with interferon alfa 2b and ribavirin for chronic HEPATITIS C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.,40-52-62-67-78-83-86-90-100-104-112-122-124-127-136-140-145-152-155-163-173-182-185-196-203-211,78-83-86-90-100-104-112-122-124-127-136-140-145-152-155-163-173-182-185-196-203-211,alfa 2b and RIBAVIRIN for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 13:24:44,1640310852,5/21/2015 13:24:24,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 13:30:15,1640313728,5/21/2015 13:29:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin for chronic HEPATITIS C,90-100-104-112-122,90-100-104-112,RIBAVIRIN for chronic hepatitis,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 13:51:18,1640324374,5/21/2015 13:50:47,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 14:07:01,1640333834,5/21/2015 14:06:15,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,112,90,,,121,99,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C,104-112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352649,5/21/2015 14:18:08,1640340714,5/21/2015 14:17:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724352650,5/21/2015 11:42:39,1640265431,5/21/2015 11:42:28,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,VENTRICULAR FIBRILLATION.,94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 12:13:44,1640279222,5/21/2015 12:12:36,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,36-50-59-64,Amiodarone compared with LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 12:41:05,1640291548,5/21/2015 12:40:51,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,lidocaine VENTRICULAR FIBRILLATION.,94-106-64,64-94-106,LIDOCAINE ventricular fibrillation.,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 12:46:27,1640293808,5/21/2015 12:46:16,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,lidocaine for shock Resistant VENTRICULAR FIBRILLATION.,74-78-84-94-106-64,47-50-59-64-74-78-84-36,Amiodarone as compared with LIDOCAINE for shock Resistant,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 13:01:55,1640300144,5/21/2015 13:01:46,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,50-59-64-74-78-84,compared with LIDOCAINE for shock Resistant,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 13:07:41,1640302515,5/21/2015 13:07:25,false,instagc,1.0,15285653,USA,"","",172.162.76.35,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,compared with lidocaine for shock Resistant VENTRICULAR FIBRILLATION.,50-59-74-78-84-94-106-64,36-47-50-59-64-74-78-84-94-106,Amiodarone as compared with LIDOCAINE for shock Resistant ventricular fibrillation.,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 13:24:22,1640310776,5/21/2015 13:24:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,VENTRICULAR FIBRILLATION.,94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 13:29:55,1640313564,5/21/2015 13:29:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,for shock Resistant VENTRICULAR FIBRILLATION.,74-78-84-94-106,50-59-64,compared with LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 13:50:46,1640324086,5/21/2015 13:50:22,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,VENTRICULAR FIBRILLATION.,94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352650,5/21/2015 14:06:12,1640333215,5/21/2015 14:05:52,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,VENTRICULAR FIBRILLATION.,94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724352651,5/21/2015 07:22:14,1640135285,5/21/2015 07:21:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,30,59,,,40,66,BABESIOSIS,BABESIA,Babesiosis Treatment of BABESIOSIS + caused by Babesia microti.,5-17-27-30-48-55-59-67-43,5-17-27-43-48-55-59-67-30,Babesiosis Treatment of babesiosis + caused by BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 07:36:27,1640142717,5/21/2015 07:35:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 07:51:08,1640150432,5/21/2015 07:50:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 07:58:20,1640154411,5/21/2015 07:57:56,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 08:00:06,1640155361,5/21/2015 07:59:53,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,30,59,,,40,66,BABESIOSIS,BABESIA,Babesiosis Treatment of BABESIOSIS caused by Babesia microti.,5-17-27-30-48-55-59-67,5-43-48-55-59-67-30,Babesiosis babesiosis + caused by BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 08:08:57,1640160136,5/21/2015 08:08:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,48-59-67-55,caused by BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 08:25:47,1640169303,5/21/2015 08:25:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 08:28:31,1640170707,5/21/2015 08:27:54,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 09:07:03,1640190513,5/21/2015 09:06:51,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352651,5/21/2015 09:12:57,1640193766,5/21/2015 09:12:31,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724352652,5/21/2015 11:41:32,1640264840,5/21/2015 11:41:18,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,101,83,,,111,89,MYELOPATHY,HTLV-I,MYELOPATHY,101,83-88,HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 11:50:50,1640269117,5/21/2015 11:49:52,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,101,83,,,111,89,MYELOPATHY,HTLV-I,"Therapeutic trials in 200 patients wi<span id=""transmark""></span>th HTLV I associated MYELOPATHY",43-55-62-65-69-83-88-90-101-78,83-88-90-101-112-121-129,"HTLV I associated myelopathy tropical spastic parapare<span id=""transmark""></span>sis.","Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 12:39:16,1640290702,5/21/2015 12:38:52,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I MYELOPATHY,83-101-88,83-88-90-101-112-121-129,HTLV I associated myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 12:45:01,1640293218,5/21/2015 12:44:49,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,101,83,,,111,89,MYELOPATHY,HTLV-I,Therapeutic trials HTLV I associated MYELOPATHY tropical spastic paraparesis.,43-83-88-90-101-112-121-129-55,43-55-65-69-78-83-88-90-101-112-121-129,Therapeutic trials 200 patients with HTLV I associated myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 12:59:34,1640299208,5/21/2015 12:59:05,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical spastic paraparesis.,83-88-90-101-112-121-129,83-88-90-101-112,HTLV I associated myelopathy tropical,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 13:03:52,1640300874,5/21/2015 13:03:35,false,instagc,1.0,15285653,USA,"","",172.162.76.35,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical spastic paraparesis.,83-88-90-101-112-121-129,65-69-78-83-88-90-101-112-121-129,200 patients with HTLV I associated myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 13:17:16,1640307169,5/21/2015 13:15:59,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY,83-88-90-101,83-88-90-101,HTLV I associated myelopathy,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 13:21:56,1640309551,5/21/2015 13:21:17,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,101,83,,,111,89,MYELOPATHY,HTLV-I,- MYELOPATHY,89-101,83-88,HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 13:27:55,1640312503,5/21/2015 13:26:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY paraparesis.,83-88-90-101-129,65-69-78-83-88,200 patients with HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352652,5/21/2015 13:46:01,1640321596,5/21/2015 13:45:29,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,101,83,,,111,89,MYELOPATHY,HTLV-I,I associated MYELOPATHY tropical paraparesis.,88-90-101-112-129,65-69-78-83-88-90-101,200 patients with HTLV I associated myelopathy,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724352653,5/21/2015 10:00:14,1640217193,5/21/2015 09:59:55,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 10:27:01,1640230029,5/21/2015 10:26:07,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 10:39:16,1640235932,5/21/2015 10:39:01,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 10:50:58,1640242318,5/21/2015 10:50:34,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 10:56:33,1640245039,5/21/2015 10:55:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 10:59:30,1640246536,5/21/2015 10:59:06,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA Symptoms suggesting possible,53-65-74-85,273-294-306-315-319-285,History Physical Examination Elements for RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 11:24:57,1640257397,5/21/2015 11:24:24,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,53,319,,,62,322,HEMATURIA,RCC,Episodes of HEMATURIA,41-50-53,273-281-294-306-315-319-285,"History and Physi<span id=""transmark""></span>cal Examination Elements for RCC.","• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 11:38:09,1640263278,5/21/2015 11:37:57,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 11:55:53,1640271496,5/21/2015 11:55:18,false,clixsense,1.0,15673340,CAN,ON,Dundas,174.88.17.69,53,319,,,62,322,HEMATURIA,RCC,"◊ Episodes of HEMATURIA Symptoms suggesting possible metastatic disease,",39-41-50-53-65-74-85-94-105,294-306-315-319,Examination Elements for RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352653,5/21/2015 12:20:36,1640282307,5/21/2015 12:19:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724352654,5/21/2015 09:27:22,1640200821,5/21/2015 09:27:09,false,clixsense,1.0,29688032,NLD,05,Heerlen,84.25.151.248,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 09:32:08,1640203325,5/21/2015 09:31:56,false,neodev,1.0,31911309,NLD,16,Almere,83.163.218.253,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75,ESTROGEN,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 09:57:04,1640215452,5/21/2015 09:56:46,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:23:39,1640228669,5/21/2015 10:23:26,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101-83,"ESTROGEN - dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:35:24,1640234015,5/21/2015 10:35:11,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"endometrial cancer, THROMBOEMBOLIC DISEASE, acute liver disease,",109-121-129-144-153-159-165,61-69-72-75-84-94-101,"history of an ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:36:21,1640234442,5/21/2015 10:36:05,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:48:00,1640240690,5/21/2015 10:47:47,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:49:19,1640241369,5/21/2015 10:48:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:50:00,1640241821,5/21/2015 10:49:51,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352654,5/21/2015 10:54:06,1640243828,5/21/2015 10:52:32,false,clixsense,1.0,22984878,CAN,ON,Kingston,67.193.186.57,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"estrogen cancer, endometrial cancer, THROMBOEMBOLIC DISEASE, acute liver disease,",101-109-121-129-144-153-159-165-75,61-69-72-75-84-94-101-109-121-129-144,"history of an ESTROGEN dependent breast cancer, endometrial cancer, thromboembolic disease,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724352655,5/21/2015 10:02:51,1640218479,5/21/2015 10:02:13,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 10:29:02,1640230963,5/21/2015 10:28:37,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 10:42:01,1640237429,5/21/2015 10:41:45,false,clixsense,1.0,6338946,CAN,ON,Ottawa,23.91.230.44,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 10:52:33,1640243028,5/21/2015 10:52:20,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 11:00:13,1640246878,5/21/2015 10:59:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS, blepharitides,",63-79,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 11:36:46,1640262582,5/21/2015 11:36:01,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29-44-47-58-63-79-94-98,"DKC is associated with conjunctivitis, blepharitides, and pter<span id=""transmark""></span>ygium.","Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 11:39:48,1640264100,5/21/2015 11:39:36,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 12:35:48,1640289099,5/21/2015 12:35:27,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,63,29,,,77,32,CONJUNCTIVITIS,DKC,"DKC CONJUNCTIVITIS,",63-29,29-63-79-94-98,"DKC conjunctivitis, blepharitides, and pterygium.","Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 12:42:38,1640292277,5/21/2015 12:42:24,false,prodege,1.0,3587109,CAN,NS,Mabou,47.55.139.253,63,29,,,77,32,CONJUNCTIVITIS,DKC,"DKC reportedly is associated with CONJUNCTIVITIS, blepharitides, and pterygium.",29-44-47-58-63-79-94-98-33,0-11-18-27-29-33-44-47-58-63,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis,","Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724352655,5/21/2015 12:55:46,1640297639,5/21/2015 12:55:11,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,63,29,,,77,32,CONJUNCTIVITIS,DKC,"DKC reportedly is associated with CONJUNCTIVITIS,",29-44-47-58-63-33,11-18-27-29-33-44-47-58-63,"system findings : DKC reportedly is associated with conjunctivitis,","Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
